<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005537.pub2" GROUP_ID="SYMPT" ID="486605021509504295" MERGED_FROM="" MODIFIED="2016-10-14 10:42:03 +0100" MODIFIED_BY="Anna Erskine" REVIEW_NO="125" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.0">
<COVER_SHEET MODIFIED="2016-10-14 10:42:02 +0100" MODIFIED_BY="Anna Erskine">
<TITLE>Psychotherapy for depression among incurable cancer patients</TITLE>
<CONTACT MODIFIED="2016-10-14 10:42:02 +0100" MODIFIED_BY="Anna Erskine"><PERSON ID="408B998182E26AA200FFCE21C0DFD909" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Toru</FIRST_NAME><LAST_NAME>Okuyama</LAST_NAME><EMAIL_1>okuyama@med.nagoya-cu.ac.jp</EMAIL_1><ADDRESS><DEPARTMENT>Department of Psychiatry &amp; Cognitive-Behavioral Medicine</DEPARTMENT><ORGANISATION>Nagoya City University Graduate School of Medical Sciences</ORGANISATION><ADDRESS_1>Kawasumi, Mizuho-cho, Mizuho-ku</ADDRESS_1><CITY>Nagoya</CITY><ZIP>467-8601</ZIP><REGION>Aichi</REGION><COUNTRY CODE="JP">Japan</COUNTRY><PHONE_1>+81-52-853-8271</PHONE_1><FAX_1>+81-52-852-0837</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2016-10-14 10:42:02 +0100" MODIFIED_BY="Anna Erskine"><PERSON ID="E82A1EAD82E26AA200334BFE684EACC0" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Tatsuo</FIRST_NAME><LAST_NAME>Akechi</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>takechi@med.nagoya-cu.ac.jp</EMAIL_1><ADDRESS><DEPARTMENT>Department of Psychiatry &amp; Cognitive-Behavioral Medicine</DEPARTMENT><ORGANISATION>Nagoya City University Graduate School of Medical Sciences</ORGANISATION><ADDRESS_1>Mizuho-cho, Mizuho-ku</ADDRESS_1><CITY>Nagoya</CITY><ZIP>467 8601</ZIP><REGION>Aichi</REGION><COUNTRY CODE="JP">Japan</COUNTRY><PHONE_1>+81 52 853 8271</PHONE_1><FAX_1>+81 52 852 0837</FAX_1></ADDRESS></PERSON><PERSON ID="408B998182E26AA200FFCE21C0DFD909" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Toru</FIRST_NAME><LAST_NAME>Okuyama</LAST_NAME><EMAIL_1>okuyama@med.nagoya-cu.ac.jp</EMAIL_1><ADDRESS><DEPARTMENT>Department of Psychiatry &amp; Cognitive-Behavioral Medicine</DEPARTMENT><ORGANISATION>Nagoya City University Graduate School of Medical Sciences</ORGANISATION><ADDRESS_1>Kawasumi, Mizuho-cho, Mizuho-ku</ADDRESS_1><CITY>Nagoya</CITY><ZIP>467-8601</ZIP><REGION>Aichi</REGION><COUNTRY CODE="JP">Japan</COUNTRY><PHONE_1>+81-52-853-8271</PHONE_1><FAX_1>+81-52-852-0837</FAX_1></ADDRESS></PERSON><PERSON ID="E834D8B582E26AA200334BFEE9894E2A" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Joji</FIRST_NAME><LAST_NAME>Onishi</LAST_NAME><POSITION>Graduate Student</POSITION><EMAIL_1>j-onishi@med.nagoya-u.ac.jp</EMAIL_1><ADDRESS><DEPARTMENT>Department of Geriatrics</DEPARTMENT><ORGANISATION>Nagoya University Graduate School of Medicine</ORGANISATION><ADDRESS_1>65 Tsurumai-cho, Schowa-ku</ADDRESS_1><CITY>Nagoya</CITY><ZIP>466-8550</ZIP><REGION>Aichi</REGION><COUNTRY CODE="JP">Japan</COUNTRY><PHONE_1>+81 52 744 2364</PHONE_1></ADDRESS></PERSON><PERSON ID="E8373BCB82E26AA200334BFE1059E0D8" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Tatsuya</FIRST_NAME><LAST_NAME>Morita</LAST_NAME><POSITION>Section Head</POSITION><EMAIL_1>tmorita@sis.seirei.or.jp</EMAIL_1><ADDRESS><DEPARTMENT>Seirei Hospice</DEPARTMENT><ORGANISATION>Seirei Mikatabara Hospital</ORGANISATION><ADDRESS_1>Palliative care team and Seirei Hospice</ADDRESS_1><ADDRESS_2>3453 Mikatabara-cho</ADDRESS_2><CITY>Hamamatsu</CITY><ZIP>433 8558</ZIP><REGION>Shizuoka</REGION><COUNTRY CODE="JP">Japan</COUNTRY><PHONE_1>+81 53 436 1251</PHONE_1><FAX_1>+81 53 438 2971</FAX_1></ADDRESS></PERSON><PERSON ID="13142" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Toshi</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Furukawa</LAST_NAME><POSITION>Professor and Chair</POSITION><EMAIL_1>furukawa@kuhp.kyoto-u.ac.jp</EMAIL_1><URL>http://ebmh.med.kyoto-u.ac.jp/</URL><ADDRESS><DEPARTMENT>Department of Health Promotion and Human Behavior</DEPARTMENT><ORGANISATION>Kyoto University Graduate School of Medicine/School of Public Health</ORGANISATION><ADDRESS_1>Yoshida Konoe-cho, Sakyo-ku,</ADDRESS_1><CITY>Kyoto</CITY><ZIP>606-8501</ZIP><COUNTRY CODE="JP">Japan</COUNTRY><PHONE_1>+81 75 753 9491</PHONE_1><FAX_1>+81 75 753 4641</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2013-06-17 13:31:13 +0100" MODIFIED_BY="Laila Tyrrell">
<UP_TO_DATE>
<DATE DAY="11" MONTH="2" YEAR="2008"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="5" MONTH="9" YEAR="2005"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="5" MONTH="5" YEAR="2014"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2005"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2008"/>
</DATES>
<WHATS_NEW MODIFIED="2016-10-14 10:40:03 +0100" MODIFIED_BY="Anna Erskine">
<WHATS_NEW_ENTRY EVENT="STABLE" MODIFIED="2016-10-14 10:40:03 +0100" MODIFIED_BY="Anna Erskine">
<DATE DAY="14" MONTH="10" YEAR="2016"/>
<DESCRIPTION>
<P>See <LINK TAG="PUBLIC_NOTES" TYPE="SECTION">Published notes</LINK>.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2016-10-14 10:39:52 +0100" MODIFIED_BY="Anna Erskine">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-10-14 10:39:52 +0100" MODIFIED_BY="Anna Erskine">
<DATE DAY="17" MONTH="6" YEAR="2013"/>
<DESCRIPTION>
<P>There has been a delay in updating this review. The authors are in the process of updating and we anticipate publication in early 2014.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-06-17 13:30:04 +0100" MODIFIED_BY="Anna Hobson">
<DATE DAY="24" MONTH="9" YEAR="2010"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-09-24 11:41:09 +0100" MODIFIED_BY="Jessica Thomas">
<DATE DAY="7" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Further adjustments for RevMan 5 conversion.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-11-07 00:03:50 +0000" MODIFIED_BY="Jessica R Thomas">
<DATE DAY="9" MONTH="7" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Nagoya City University Medical School</NAME>
<COUNTRY CODE="JP">Japan</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Japanese Ministry of Health, Labor and Welfare</NAME>
<COUNTRY CODE="JP">Japan</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-10-14 10:40:18 +0100" MODIFIED_BY="Anna Erskine">
<SUMMARY>
<TITLE>Psychotherapy for depression among cancer patients who are incurable</TITLE>
<SUMMARY_BODY>
<P>Depressive states represent frequent complications among cancer patients and are more common amongst advanced cancer patients. Psychotherapy comprises of various interventions for ameliorating or preventing psychological distress conducted by direct verbal or interactive communication, or both, and is delivered by health care professionals. It is a patient-preferred and promising strategy for treating depressive states among cancer patients. Several systematic reviews have investigated the effectiveness of psychotherapy for treating depressive states among cancer patients. However, the findings are conflicting, and no review has focused on depressive states among patients with incurable cancer. The review authors conducted a systematic review of randomised controlled trials to investigate the effects of psychotherapy on the treatment of depressive states among patients with advanced cancer. The review authors found that psychotherapy was useful for treating depressive states in advanced cancer patients. However, little evidence supports the effectiveness of psychotherapy for patients with clinically diagnosed depression including major depressive disorder. Future studies to investigate and clarify the usefulness of psychotherapy for treating clinically diagnosed depression in terminally ill patients are needed.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>The most common psychiatric diagnosis among cancer patients is depression; this diagnosis is even more common among patients with advanced cancer. Psychotherapy is a patient-preferred and promising strategy for treating depression among cancer patients. Several systematic reviews have investigated the effectiveness of psychological treatment for depression among cancer patients. However, the findings are conflicting, and no review has focused on depression among patients with incurable cancer.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To investigate the effects of psychotherapy for treating depression among patients with advanced cancer by conducting a systematic review of randomized controlled trials (RCTs).</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>We searched the Cochrane Pain, Palliative and Supportive Care Group Register, The Cochrane Controlled Trials Register, MEDLINE, EMBASE, CINAHL, and PsycINFO databases in September 2005.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>All relevant RCTs comparing any kind of psychotherapy with conventional treatment for adult patients with advanced cancer were eligible for inclusion. Two independent review authors identified relevant studies.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two review authors independently extracted data from the original reports using standardized data extraction forms. Two independent review authors also assessed the methodological quality of the selected studies according to the recommendations of a previous systematic review of psychological therapies for cancer patients that utilized ten internal validity indicators. The primary outcome was the standardized mean difference (SMD) of change between the baseline and immediate post-treatment scores.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>We identified a total of ten RCTs (total of 780 participants); data from six studies were used for meta-analyses (292 patients in the psychotherapy arm and 225 patients in the control arm). Among these six studies, four studies used supportive psychotherapy, one adopted cognitive behavioural therapy, and one adopted problem-solving therapy. When compared with treatment as usual, psychotherapy was associated with a significant decrease in depression score (SMD = -0.44, 95% confidence interval [CI] = -0.08 to -0.80). None of the studies focused on patients with clinically diagnosed depression.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>Evidence from RCTs of moderate quality suggest that psychotherapy is useful for treating depressive states in advanced cancer patients. However, no evidence supports the effectiveness of psychotherapy for patients with clinically diagnosed depression.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-11-07 00:11:39 +0000" MODIFIED_BY="Jessica R Thomas">
<BACKGROUND>
<P>Cancer is a life-threatening disease that often impacts on a patient's welfare and well-being; attention to these issues is thus an important aspect of comprehensive patient care. Derogatis <I>et al</I>. found that 50% of cancer patients are diagnosed with a psychiatric disorder. The most common psychiatric diagnosis was depressive disorders, including adjustment disorder with depressed mood (12%) or mixed emotional features (13%) or unipolar major depression, (4%) or both (<LINK REF="REF-Derogatis-1983" TYPE="REFERENCE">Derogatis 1983</LINK>). Other studies have consistently indicated that these depressive disorders represent common forms of psychological distress experienced by cancer patients (<LINK REF="REF-Akechi-2001" TYPE="REFERENCE">Akechi 2001</LINK>; <LINK REF="REF-Kugaya-2000" TYPE="REFERENCE">Kugaya 2000</LINK>; <LINK REF="REF-Okamura-2000" TYPE="REFERENCE">Okamura 2000</LINK>) and are more common in patients with advanced cancer (<LINK REF="REF-Bukberg-1984" TYPE="REFERENCE">Bukberg 1984</LINK>; <LINK REF="REF-Kugaya-2000" TYPE="REFERENCE">Kugaya 2000</LINK>). Thus depression is one of the most widely recognized psychiatric disorders in cancer patients (<LINK REF="REF-McDaniel-1995" TYPE="REFERENCE">McDaniel 1995</LINK>). Depression not only produces serious suffering (<LINK REF="REF-Block-2000" TYPE="REFERENCE">Block 2000</LINK>), but also worsens quality of life (<LINK REF="REF-Grassi-1996" TYPE="REFERENCE">Grassi 1996</LINK>), reduces compliance with anti-cancer treatment (<LINK REF="REF-Colleoni-2000" TYPE="REFERENCE">Colleoni 2000</LINK>), can lead to suicide (<LINK REF="REF-Henriksson-1995" TYPE="REFERENCE">Henriksson 1995</LINK>), is a psychological burden on the family (<LINK REF="REF-Cassileth-1985" TYPE="REFERENCE">Cassileth 1985</LINK>), and prolongs hospitalization (<LINK REF="REF-Prieto-2002" TYPE="REFERENCE">Prieto 2002</LINK>). Thus, the appropriate management of depression in cancer patients is critically important.</P>
<P>One patient-preferred and promising strategy for treating depression among cancer patients is psychotherapy (<LINK REF="REF-Okuyama-2007" TYPE="REFERENCE">Okuyama 2007</LINK>). Here, the term 'psychotherapy' is defined as various kinds of interventions for ameliorating or preventing psychological distress conducted by direct verbal or interactive communication, or both, delivered by health care professionals. Several meta-analyses and systematic reviews investigating the effectiveness of psychosocial treatment for depression among cancer patients have been performed. However, the findings of these reports are conflicting (<LINK REF="REF-Devine-1995" TYPE="REFERENCE">Devine 1995</LINK>; <LINK REF="REF-Newell-2002" TYPE="REFERENCE">Newell 2002</LINK>; <LINK REF="REF-Ross-2002" TYPE="REFERENCE">Ross 2002</LINK>; <LINK REF="REF-Sheard-1999" TYPE="REFERENCE">Sheard 1999</LINK>), and no review to date has addressed the effectiveness of psychotherapy for treating depression among incurable cancer patients.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-11-07 00:05:04 +0000" MODIFIED_BY="Jessica R Thomas">
<OL>
<LI>The primary objective of this review was to investigate the effectiveness of psychotherapy for treating any kind of depression in incurable cancer patients.</LI>
<LI>The review also evaluated the effectiveness of psychotherapy on:</LI>
</OL>
<UL>
<LI>anxiety,</LI>
<LI>general psychological distress,</LI>
<LI>control of cancer symptoms,</LI>
<LI>quality of life,</LI>
<LI>coping measures for patients,</LI>
<LI>severity of physical symptoms such as pain.</LI>
</UL>
</OBJECTIVES>
<METHODS MODIFIED="2008-11-07 00:11:39 +0000" MODIFIED_BY="Jessica R Thomas">
<SELECTION_CRITERIA MODIFIED="2008-11-07 00:06:23 +0000" MODIFIED_BY="Jessica R Thomas">
<CRIT_STUDIES>
<P>All relevant randomised controlled trials (RCTs) comparing any kind of psychotherapy with conventional treatment (treatment as usual).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>The study participants were limited to adults (18 years or older) of either sex with any primary diagnosis of incurable cancer. Their depression had to be assessed by validated measures, such as standardized self-report questionnaires or clinical interviews (e.g., Structured Clinical Interview for major depressive episode based on DSM-IV). A concurrent diagnosis of another physical disease was not a criteria for exclusion.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Studies involving psychotherapy of any kind were included in the review. We were interested in the effect of a broad range of psychological interventions, including several unique interventions, such as music therapy, that may be used in a palliative care setting. On the other hand, interventions that were not considered as forms of psychotherapy (e.g., aromatherapy, therapeutic touch) were not included. This broad range of non-pharmacological interventions were further divided into:<BR/>A: interventions by direct verbal or interactive communication, or both, delivered by health care professionals; and <BR/>B: non-pharmacological interventions other than the aforementioned ones.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-11-07 00:06:23 +0000" MODIFIED_BY="Jessica R Thomas">
<P>
<B>
<I>
<BR/>Tolerability of the treatment was to be evaluated using the following outcome measures:</I>
</B>
<BR/>1) Number of patients dropping out of the study for any reason.</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-11-07 00:05:18 +0000" MODIFIED_BY="Jessica R Thomas">
<P>The studies had to include at least one measure of the severity of depression, which was set as the primary outcome of this systematic review. Symptom severity could be measured either by self-reporting or rating by an observer.</P>
<P>Effectiveness was to be evaluated using the group mean scores of these continuous depression severity scales (this planned analytical method was modified in the completed review (<I>See</I> '<LINK TAG="RESULTS" TYPE="SECTION">Results</LINK>')).</P>
<P>Outcomes were to be measured at the end of the study. Where possible, these indices of effectiveness would be pooled at different time points in the course of treatment, such as at one month, three months, six months and so on. In addition, when studies provided data regarding ongoing effectiveness after treatment termination, this data was also to be pooled (this planned method was modified (<I>See '</I>data synthesis').</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2008-11-07 00:06:23 +0000" MODIFIED_BY="Jessica R Thomas">
<OL>
<LI>No of patients who 'responded' to treatment according to the original study authors' definition.</LI>
<LI>Anxiety, as measured using scales like the Hamilton Anxiety Rating scale, the State-Trait Anxiety Inventory, and the Hospital Anxiety and Depression Scale.</LI>
<LI>General psychological distress, as measured using scales like the Profile of Mood States (total mood disturbance) and the General Health Questionnaire.</LI>
<LI>Quality of life, as measured using scales like the European Organization for Research and Treatment of Cancer (EORTC) quality of life questionnaire, the Functional Assessment of Cancer Therapy-General (FACT-G) scale, and the Medical Outcome Study Short-Form 36-item survey.</LI>
<LI>Severity of physical symptoms like pain, as measured using scales like the Brief Pain Inventory (BPI) and visual analogue scale (VAS).</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-11-07 00:11:39 +0000" MODIFIED_BY="Jessica R Thomas">
<SUBSECTION>
<HEADING LEVEL="3">1. Electronic databases</HEADING>
<P>To identify studies for inclusion in this review, detailed search strategies were developed for each electronic database searched in September 2005. These strategies were based on the search strategy developed for MEDLINE (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>) but were revised appropriately for each database and are included in additional <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">2. Reference search</HEADING>
<P>The references of all selected studies were inspected for more published reports and citations of unpublished studies. In addition, other relevant review papers were checked.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">3. SciSearch</HEADING>
<P>All the selected studies were sought as a citation in the SciSearch database to identify additional studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">4. Personal communication</HEADING>
<P>To ensure that all RCTs were identified, the authors of significant papers were contacted.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">5. Language</HEADING>
<P>No language restrictions were applied when selecting studies.</P>
</SUBSECTION>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-11-07 00:07:50 +0000" MODIFIED_BY="Jessica R Thomas">
<SUBSECTION>
<HEADING LEVEL="3">1. Selection of studies</HEADING>
<P>In September 2005, two review authors (TA and JO) checked hard copies of the references identified by the search strategy to identify studies meeting the following broad and simple criteria:<BR/>i) randomised trials;<BR/>ii) incurable cancer patients (this included subjects with incurable, advanced, metastatic, or terminal cancer. When the participants were mixed-stage cancer patients, studies in which more than 80% of the participants had an advanced stage of cancer (stage III, IV, or recurrent) were eligible for inclusion in the review); and<BR/>iii) assessment of depression.</P>
<P>The inter-rater reliability of the two raters were evaluated using percentage agreement and kappa coefficient. All studies identified by either of the two raters were then subjected to the next stage of critical appraisal according to the strict eligibility criteria.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">2. Quality assessment</HEADING>
<P>Two independent review authors (TA and TO) assessed the methodological quality of the selected studies. We used Newell's methodological quality criteria (<LINK REF="REF-Newell-2002" TYPE="REFERENCE">Newell 2002</LINK>), which includes the following points:<BR/>i) adequate concealment of allocation;<BR/>ii) patients randomly selected;<BR/>iii) patients blinded to treatment group;<BR/>iv) care-providers blinded to treatment group;<BR/>v) except for study intervention, equivalence of other treatments;<BR/>vi) care-providers' adherence monitored;<BR/>vii) detailed lost-to-follow-up information;<BR/>viii) percentage of patients not included in analyses;<BR/>ix) intention-to-treat analyses; and<BR/>x) outcomes measured in a blinding fashion.</P>
<P>The maximum score for each study was 30 points, with higher scores indicating higher quality. As previously reported, the quality of a study was considered to be good if the study had a total score greater than 20 points, fair if it scored 11 to 20 points, and poor if it scored less than 11 points (<LINK REF="REF-Newell-2002" TYPE="REFERENCE">Newell 2002</LINK>).</P>
<P>The inter-rater reliability of these validity criteria was evaluated using Cohen's weighted kappa. Those studies with clearly inadequate concealment of random allocation were excluded. The influences of the other quality indices were examined using sensitivity analyses.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">3. Data extraction</HEADING>
<P>Two review authors (TA and TO) independently extracted data from the original reports using data extraction forms. Any disagreement was resolved by consensus between the two or, where necessary, between all the review authors. Extracted data included the country of origin, the nature and content of psychological intervention and the patient group involved, the duration of the study, the study setting, the sample size, and the key outcomes using validated instruments.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">4. Data synthesis</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Planned method</HEADING>
<P>Data were to be entered by JO into Review Manager 4.2.10 twice, using the duplicate data entry feature. For dichotomous outcomes, the relative risk (RR) and their 95% confidence intervals (CI) were to be calculated using the random-effects model, since the RR of the random-effects model has been shown to be superior in clinical interpretability and external generalisability than the fixed-effect models and odds ratios (OR) or risk differences (<LINK REF="REF-Furukawa-2002" TYPE="REFERENCE">Furukawa 2002</LINK>). The heterogeneity among the studies was to be assessed using the I-squared and Q statistics and by visual inspection of the results in the Meta View plots. An I<SUP>2</SUP> greater than 30% or a Q statistic P value of less than 0.1 was to be considered indicative of heterogeneity. If significant heterogeneity was suspected, the sources were to be investigated. For dichotomous outcomes of response, two analytical strategies were to be adopted; first, a 'per protocol' analysis was to be performed according to the values reported by the original authors. When data on dropouts were included, usually by way of the last-observation-carried-forward (LOCF) method, this data was to be analysed according to the primary studies. For continuous outcomes, the standardized mean difference (SMD) was to be pooled using the random-effects model. Continuous outcomes were to be analysed on an endpoint basis, including only patients with a final assessment or with a last observation carried forward to the final assessment. A strict ITT analysis was not feasible with continuous outcomes, as the studies performed only LOCF or endpoint analyses.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Actual method</HEADING>
<P>Data were entered by TA into Review Manager 4.2.10 twice using the duplicate data entry feature. Analysis of dichotomous outcomes was planned, but only one study (<LINK REF="STD-Wu-2003" TYPE="STUDY">Wu 2003</LINK>) included this. Post-treatment scores were available in three studies (<LINK REF="STD-Wu-2003" TYPE="STUDY">Wu 2003</LINK>; <LINK REF="STD-Liossi-2001" TYPE="STUDY">Liossi 2001</LINK>; <LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>) while change scores were available or could be calculated in six studies (<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Wood-1997" TYPE="STUDY">Wood 1997</LINK>; <LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>; <LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>). We therefore modified the data synthesis method during the review because the data obtained could not be synthesized appropriately using the planned method. The change between the baseline and immediate post-treatment scores was selected as the primary outcome for the meta-analysis (<LINK REF="REF-Banerjee-2006" TYPE="REFERENCE">Banerjee 2006</LINK>). The SMD and 95% CIs were pooled using a random-effects model (<LINK REF="REF-Alderson-2004" TYPE="REFERENCE">Alderson 2004</LINK>). Two studies provided data on the results of slope analyses (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>), and we calculated the change scores using these data. One paper provided raw data only (<LINK REF="STD-Wood-1997" TYPE="STUDY">Wood 1997</LINK>); for these data, we calculated the change score using SPSS 10.0J version software for Windows (<LINK REF="REF-SPSS-2003" TYPE="REFERENCE">SPSS 2003</LINK>). In addition, because we could not obtain the actual figures for the standard deviations in the change scores for depression, anxiety, and general psychological distress in two studies (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>), we calculated the pooled standard deviations in the other available studies that utilized the same measuring instrument (the Profile of Mood States) (<LINK REF="REF-MaNair-1992" TYPE="REFERENCE">MaNair 1992</LINK>) (<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>; <LINK REF="STD-Wood-1997" TYPE="STUDY">Wood 1997</LINK>) and these values were inputted for the missing data (<LINK REF="REF-Furukawa-2006" TYPE="REFERENCE">Furukawa 2006</LINK>).</P>
<P>The heterogeneity among the studies was assessed using the I<SUP>2</SUP> and Q statistics and by visual inspection of the results in Meta View plots. An I<SUP>2</SUP> value greater than 30% or a Q statistic with a P value less than 0.1 were considered indicative of heterogeneity. If significant heterogeneity was suspected, the source of it was investigated.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">5. Subgroup analyses</HEADING>
<P>Subgroup analyses should be performed and interpreted with caution because multiple analyses can lead to false-positive conclusions (<LINK REF="REF-Oxman-1992" TYPE="REFERENCE">Oxman 1992</LINK>). However, we performed the following subgroup analyses, if possible, for the following <I>a priori </I>reasons:<BR/>
</P>
<UL>
<LI>A separate analysis was performed for participants who received group psychotherapy, since different modalities of psychotherapy (i.e., group versus individual) could have different effects.</LI>
<LI>A separate analysis was performed for breast cancer patients, because many psycho-oncology studies focus on this patient group.</LI>
<LI>A separate analysis was performed for participants with clinical depression based on any cut-off points or diagnostic criteria of depression measures, because the effect of psychotherapy on depression may differ according to the baseline depressive status.</LI>
<LI>A separate analysis was performed for participants receiving interventions by direct verbal or interactive communication delivered by health care professionals, or both, because this type of psychotherapy may have a different effect on depression.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">6. Funnel plot analysis and sensitivity analyses:</HEADING>
<UL>
<LI>A funnel plot analysis was performed to check for any publication bias.</LI>
<LI>A sensitivity analysis was performed, if possible, to examine the robustness of the observed findings by repeating all the analyses using only high-quality studies.</LI>
</UL>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-11-07 00:08:17 +0000" MODIFIED_BY="Jessica R Thomas">
<STUDY_DESCRIPTION>
<P>Two independent review authors checked the studies identified by the search sources, and a total of 176 studies were extracted for possible inclusion. Full copies of these articles were obtained, and the two independent review authors then examined the strict eligibility of these papers. Further reference searches and a SciSearch did not yield any additional studies that satisfied the strict eligibility criteria. The inter-rater reliability of the strict eligibility criteria were as follows: kappa coefficient, 0.84, percent concordance, 95.5%.</P>
<P>First, we identified 16 studies that were potentially suitable for inclusion (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Giasson-1998" TYPE="STUDY">Giasson 1998</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Laidlaw-2005" TYPE="STUDY">Laidlaw 2005</LINK>; <LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>; <LINK REF="STD-Liossi-2001" TYPE="STUDY">Liossi 2001</LINK>; <LINK REF="STD-Mantovani-1996" TYPE="STUDY">Mantovani 1996</LINK>; <LINK REF="STD-North-1992" TYPE="STUDY">North 1992</LINK>; <LINK REF="STD-Sarna-1998" TYPE="STUDY">Sarna 1998</LINK>; <LINK REF="STD-Schofield-2003" TYPE="STUDY">Schofield 2003</LINK>; <LINK REF="STD-Sloman-2002" TYPE="STUDY">Sloman 2002</LINK>; <LINK REF="STD-Soden-2004" TYPE="STUDY">Soden 2004</LINK>; <LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>; <LINK REF="STD-Wood-1997" TYPE="STUDY">Wood 1997</LINK>; <LINK REF="STD-Wu-2003" TYPE="STUDY">Wu 2003</LINK>). However, five of these studies (<LINK REF="STD-Giasson-1998" TYPE="STUDY">Giasson 1998</LINK>; <LINK REF="STD-North-1992" TYPE="STUDY">North 1992</LINK>; <LINK REF="STD-Sarna-1998" TYPE="STUDY">Sarna 1998</LINK>; <LINK REF="STD-Schofield-2003" TYPE="STUDY">Schofield 2003</LINK>; <LINK REF="STD-Soden-2004" TYPE="STUDY">Soden 2004</LINK>) were ultimately dropped after a discussion among the review authors because the interventions in these studies were not forms of psychotherapy. The interventions in these studies were as follows: aromatherapy (<LINK REF="STD-Soden-2004" TYPE="STUDY">Soden 2004</LINK>), a multisensory environment (<LINK REF="STD-Schofield-2003" TYPE="STUDY">Schofield 2003</LINK>), a structured nursing assessment of symptoms (<LINK REF="STD-Sarna-1998" TYPE="STUDY">Sarna 1998</LINK>), noncontact therapeutic touch (<LINK REF="STD-Giasson-1998" TYPE="STUDY">Giasson 1998</LINK>), and information provided by tape-recordings of consultations (<LINK REF="STD-North-1992" TYPE="STUDY">North 1992</LINK>). In addition, one study was excluded because of the absence of usual care in the control group (<LINK REF="STD-Mantovani-1996" TYPE="STUDY">Mantovani 1996</LINK>). Finally we identified ten studies that were suitable for inclusion (total of 780 participants) (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Laidlaw-2005" TYPE="STUDY">Laidlaw 2005</LINK>; <LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>; <LINK REF="STD-Liossi-2001" TYPE="STUDY">Liossi 2001</LINK>; <LINK REF="STD-Sloman-2002" TYPE="STUDY">Sloman 2002</LINK>; <LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>; <LINK REF="STD-Wood-1997" TYPE="STUDY">Wood 1997</LINK>; <LINK REF="STD-Wu-2003" TYPE="STUDY">Wu 2003</LINK>).</P>
<P>The subjects of the meta-analysis were recruited from three main groups: patients with metastatic breast cancer (five studies), patients who had received some form of palliative care (three studies), and various patients with advanced cancer (two studies). </P>
<P>Various types of interventions were utilized in these ten studies. Five studies (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; 
<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; 
<LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>; 
<LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>; <LINK REF="STD-Wu-2003" TYPE="STUDY">Wu 2003</LINK>) mainly used supportive psychotherapy. Three studies mainly investigated the effect of behavioural therapies, either relaxation techniques (<LINK REF="STD-Sloman-2002" TYPE="STUDY">Sloman 2002</LINK>) or hypnosis (<LINK REF="STD-Laidlaw-2005" TYPE="STUDY">Laidlaw 2005</LINK>; <LINK REF="STD-Liossi-2001" TYPE="STUDY">Liossi 2001</LINK>). The other studies used cognitive behavioural therapy (<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>) and problem-solving therapy (<LINK REF="STD-Wood-1997" TYPE="STUDY">Wood 1997</LINK>). The duration of the interventions was variable, ranging from just three to five sessions (<LINK REF="STD-Wood-1997" TYPE="STUDY">Wood 1997</LINK>) to unlimited and continuing until death (<LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>). Three of the five studies using supportive psychotherapy and the one study using cognitive behavioural therapy utilized group treatment sessions. Thus, the ten selected studies included several kinds of interventions, all of which involved direct verbal and interactive communication delivered by health care professionals (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Laidlaw-2005" TYPE="STUDY">Laidlaw 2005</LINK>; <LINK REF="STD-Liossi-2001" TYPE="STUDY">Liossi 2001</LINK>; <LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>; <LINK REF="STD-Sloman-2002" TYPE="STUDY">Sloman 2002</LINK>; <LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>; <LINK REF="STD-Wood-1997" TYPE="STUDY">Wood 1997</LINK>; <LINK REF="STD-Wu-2003" TYPE="STUDY">Wu 2003</LINK>). There were no interventions belonging to non-pharmacological interventions other than the aforementioned ones. </P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>With regard to study quality, none of the studies met the criteria for a 'good' rating. Three studies met the criteria for a 'fair' rating (<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>; <LINK REF="STD-Wu-2003" TYPE="STUDY">Wu 2003</LINK>), and the remaining seven studies were judged as having a 'poor' rating. Two studies clearly described the procedure for adequate allocation concealment (<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>).</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-11-07 00:08:17 +0000" MODIFIED_BY="Jessica R Thomas">
<P>Two studies did not report the effects of the interventions on depression (<LINK REF="STD-Laidlaw-2005" TYPE="STUDY">Laidlaw 2005</LINK>; <LINK REF="STD-Wood-1997" TYPE="STUDY">Wood 1997</LINK>), although they did measure the severity of depression among the participating subjects. As described above, all of the remaining eight studies used interventions involving direct verbal and interactive communication delivered by health care professionals (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>; <LINK REF="STD-Liossi-2001" TYPE="STUDY">Liossi 2001</LINK>; <LINK REF="STD-Sloman-2002" TYPE="STUDY">Sloman 2002</LINK>; <LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>; <LINK REF="STD-Wu-2003" TYPE="STUDY">Wu 2003</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Effects of psychotherapy on depression: meta-analyses</HEADING>
<P>Moderate and statistically significant heterogeneity among six studies (see below) was observed (P = 0.004, I<SUP>2</SUP> = 71%). The identified studies were quite heterogeneous with regard to their participants and interventions, and many studies did not include some of the data required for meta-analyses. Consequently, we decided to conduct the meta-analyses by combining the data from studies in which the change scores were available. Thus, we excluded four studies because they did not contain necessary data, such as the change score, the standard deviation of the change score, or the number of participants (<LINK REF="STD-Laidlaw-2005" TYPE="STUDY">Laidlaw 2005</LINK>; <LINK REF="STD-Liossi-2001" TYPE="STUDY">Liossi 2001</LINK>; <LINK REF="STD-Sloman-2002" TYPE="STUDY">Sloman 2002</LINK>; <LINK REF="STD-Wu-2003" TYPE="STUDY">Wu 2003</LINK>). The data from the six studies that provided all the information needed to conduct the meta-analyses were combined; all of these studies had used the Profile of Mood States as a measure of depression (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>; <LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>; <LINK REF="STD-Wood-1997" TYPE="STUDY">Wood 1997</LINK>). Among these six studies, four studies used supportive psychotherapy (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>; <LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>), one utilized cognitive behavioural therapy (<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>) and one utilized problem-solving therapy (<LINK REF="STD-Wood-1997" TYPE="STUDY">Wood 1997</LINK>). Regarding the data from the study by Linn<I> et al</I>., we decided to use the data obtained one month after intervention to minimize the effects of drop-outs, although the study provided data on depression at five time points during the intervention (<LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>).</P>
<P>The combined data from the six studies, involving 292 patients in the psychotherapy arm and 225 patients in the control arm, showed that psychotherapy had a significant effect on the treatment of depression among participants with advanced cancer (SMD = -0.44, 95% CI = -0.08 to -0.80). Visual inspection of the Meta View plots suggested that the study conducted by either Spiegel <I>et al.</I> or Wood <I>et al.</I> contributed most of the heterogeneity (<LINK REF="STD-Wood-1997" TYPE="STUDY">Wood 1997</LINK>; <LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>). While the heterogeneity indicators were similar if the study by Wood <I>et al </I>(<LINK REF="STD-Wood-1997" TYPE="STUDY">Wood 1997</LINK>) was excluded (Chi<SUP>2 </SUP>= 15.49, df = 4 (P = 0.004), I<SUP>2 </SUP>= 74%), the heterogeneity diminished and was no longer statistically significant if the study by Spiegel <I>et al</I> was excluded (Chi<SUP>
<U>2 </U>
</SUP>= 5.93, df = 4 [P = 0.20], I<SUP>2 </SUP>= 32.6%). The source of the heterogeneity was further investigated by examining the patient group, measuring instrument, type and duration of intervention, treatment of control group, outcome data and so on; however, clear factors that might have produced the heterogeneity could not be identified.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Effect of psychotherapy on anxiety and general psychological distress: meta-analyses</HEADING>
<P>Since one study did not measure anxiety (<LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>), we combined the data from five studies (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>; <LINK REF="STD-Wood-1997" TYPE="STUDY">Wood 1997</LINK>). The combined data, involving 242 patients in the psychotherapy arm and 169 patients in the control arm, showed that psychotherapy had a borderline effect on anxiety among participants with advanced cancer (SMD = -0.68, 95% CI = 0.01 to -1.37). Strong, statistically significant heterogeneity was observed (P &lt; 0.00001, I<SUP>2 </SUP>= 89.1%). Visual inspection of the Meta View plots suggested that the study conducted by Spiegel <I>et al.</I> was heterogeneous (<LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>). When this study was omitted, the significant heterogeneity was no longer observed (Chi<SUP>2</SUP> = 3.22, df = 3 [P = 0.36], I<SUP>2 </SUP>= 6.8%).</P>
<P>Four studies provided data on general psychological distress, as evaluated using the total mood disturbance score of the POMS (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>). The combined data, involving 237 participants in the psychotherapy arm and 166 participants in the control arm, showed a significant effect for psychotherapy on general psychological distress among participants with advanced cancer (SMD = -0.94, 95% CI = -0.01 to -1.87). A strong, statistically significant heterogeneity was observed (P &lt; 0.00001, I<SUP>2 </SUP>= 94.3%). Visual inspection of the Meta View plots again suggested that the study conducted by Spiegel <I>et al.</I> was heterogeneous (<LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>). When this study was omitted, the significant heterogeneity was no longer observed (Chi<SUP>2 </SUP>= 2.43, df = 2 (P = 0.30), I<SUP>2 </SUP>= 17.8%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Other secondary outcomes</HEADING>
<P>We deleted some secondary endpoints, including symptom control, quality of life, coping measures for participants, and severity of physical symptoms (like pain), because few studies provided this kind of data. In addition, we stopped checking the tolerability of the treatment and the dichotomous outcomes for the same reason.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup and sensitivity analyses</HEADING>
<P>The two planned subgroup analyses (for participants who underwent group psychotherapy and for breast cancer patients) were conducted using the same four studies that investigated the effectiveness of group psychotherapy among metastatic breast cancer patients (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Spiegel-1981" TYPE="STUDY">Spiegel 1981</LINK>). The results demonstrated similar and significant findings for all three targeted psychological symptoms: depression, anxiety, and general psychological distress.</P>
<P>The other subgroup analysis (for participants with clinical depression) was not conducted as none of the studies included the participants with clinically diagnosed depression. In addition, as described in the aforementioned section ('Effects of psychotherapy on depression: meta-analyses'), the planned subgroup analysis for participants receiving interventions via direct verbal and interactive communication delivered by health care professionals was not performed.</P>
<P>As only two studies included in the meta-analysis were judged to be of good or fair quality (<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK>), a sensitivity analysis limited to these studies was performed. However, the study conducted by Linn <I>et al.</I> did not include anxiety and general psychological distress measures, so we conducted the sensitivity analysis for depression only. The combined data, involving 152 patients in the psychotherapy arm and 101 patients in the control arm, showed that psychotherapy was significantly effective for the treatment of depression (SMD = -0.35, 95% CI = -0.06 to -0.65). Statistically significant heterogeneity was not observed (P = 0.26, I<SUP>2 </SUP>= 22.4%).</P>
<P>Although the number of included studies was small, thereby limiting the usefulness of a visual inspection of the funnel plot (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>), a visual inspection did not suggest a prominent publication bias.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-11-07 00:08:39 +0000" MODIFIED_BY="Jessica R Thomas">
<SUBSECTION>
<HEADING LEVEL="2">Current findings</HEADING>
<P>This is the first systematic review, including a meta-analysis so far as we are aware, to show the significant effectiveness of verbal and interactive psychotherapeutic intervention for treating depression among advanced cancer patients. Unfortunately, the effectiveness of other types of non-pharmacological interventions for the treatment of depression could not be analysed because the available data on this topic was insufficient.</P>
<P>Our findings suggest that the effects of psychotherapy are almost comparable to those obtained in antidepressant pharmacotherapy studies in general psychiatry settings (<LINK REF="REF-Bech-2000" TYPE="REFERENCE">Bech 2000</LINK>). On the other hand, this effect was not consistent with a previous meta-analysis of 17 clinical trials that investigated the effect of psychological interventions on depression in cancer patients (<LINK REF="REF-Sheard-1999" TYPE="REFERENCE">Sheard 1999</LINK>). This previous meta-analysis indicated an effect size of 0.19, suggesting a clinically weak or negligible effect. Since the subjects of the majority of the studies included in this previous meta-analysis were not advanced cancer patients and most of the studies had selected their patient populations based on cancer diagnosis, rather than on diagnostic or psychological criteria, or both, differences in the prevalence of clinical depression may be one possible explanation for the discrepancy between their meta-analysis and ours. In other words, since depression is common in patients with advanced cancer (<I>see </I>'Background'), this difference may account for the different findings regarding the effect of the intervention.</P>
<P>Regarding the types of verbal and interactive psychotherapeutic interventions that were included in the meta-analysis, four of the six psychotherapeutic approaches utilized supportive therapy. Probably because of the nature of the study subjects (i.e., people suffering from incurable cancer), all of the approaches involved some form of techniques dealing with the impact of life-threatening disease on patients' lives, including issues of 'dying' or 'existence', or both, in addition to general support (<LINK REF="REF-Spiegel-1978" TYPE="REFERENCE">Spiegel 1978</LINK>; <LINK REF="REF-Yalom-1977" TYPE="REFERENCE">Yalom 1977</LINK>). In addition, one of the most prominent characteristics of these four studies was the fact that the interventions essentially continued until the patients' deaths. On the other hand, specific types of psychotherapy, especially cognitive behavioural therapy, are widely recommended for the treatment of psychological distress among cancer patients; however, our systematic review highlights the need for more well-designed clinical trials to clarify the effectiveness of cognitive behavioural therapy on depression in patients with advanced cancer.</P>
<P>The findings with regard to anxiety and general psychological distress were similar to those for depression, although the results for anxiety did not reach statistical significance. These findings suggest that the psychotherapy may be useful for ameliorating a broad range of psychological distress, with the exception of anxiety experienced by advanced cancer patients.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Clinical implications and future research</HEADING>
<P>The present findings suggest that the depression experienced by advanced cancer patients, who are well-known to be at risk for developing depression or clinically profound psychological distress, or both, can be effectively ameliorated by psychotherapeutic intervention. Although our review could not clarify the cost effectiveness of psychotherapeutic interventions for patients with advanced cancer, and the fact that long-term continuous interventions requiring trained mental health professionals may not be easy to provide for all patients, our findings suggest that psychological interventions should be combined with routine patient care for the treatment of patients with advanced cancer. At the same time, clarifying the cost-effectiveness of psychotherapy and developing cost-effective interventions for treating depression among advanced cancer patients may be important future tasks.</P>
<P>Some relevant questions remain concerning the effectiveness of psychotherapy on depression among patients with incurable cancer. First, because most studies included in the meta-analysis investigated the impact of the interventions just after or during the process of continuous treatment, or both, the persistent effects of the completed interventions were unclear. Second, because most of the subjects were not clinically diagnosed as having depression, the effectiveness of psychotherapy for the treatment of clinical depression could not be clarified in this review. These clinically important issues should be addressed in future studies.</P>
<P>Finally, we would like to comment on the study quality of the psychological interventions. As reported in the previous reviews, the quality of most of the studies was problematic (<LINK REF="REF-Newell-2002" TYPE="REFERENCE">Newell 2002</LINK>; <LINK REF="REF-Williams-2006" TYPE="REFERENCE">Williams 2006</LINK>). However, given the difficulty of conducting clinical trials in this population, such as in palliative care settings and of evaluating the quality of clinical trials for psychological interventions (<LINK REF="REF-Penrod-2004" TYPE="REFERENCE">Penrod 2004</LINK>), novel and realistic quality assessment systems may be needed for studies focusing on patients with advanced cancer.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Methodological advantages of this study</HEADING>
<P>This systematic review has several major strengths. Firstly, we performed systematic and comprehensive literature searches for relevant studies, whereas previous studies contained several major flaws in their methodology, including a language bias (e.g., typically only English papers), and the combination of randomised and non-randomized clinical trials. Second, the <I>a priori </I>planned heterogeneity and sensitivity analyses indicated that the results of the analyses were quite robust.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Limitations of this study</HEADING>
<P>Our review also has some limitations. First, the reviewed studies generally had small sample sizes, and only a small number of studies (n = 6) were included in the meta-analysis. These factors may limit the validity of our findings. The existence of a possible outcome reporting bias cannot be negated (<LINK REF="REF-Chan-2005" TYPE="REFERENCE">Chan 2005</LINK>; <LINK REF="REF-Furukawa-2007" TYPE="REFERENCE">Furukawa 2007</LINK>). Secondly, although the use of data imputation for missing standard deviations of change scores was found to be valid in one study dealing with pharmacotherapy for depression (<LINK REF="REF-Furukawa-2006" TYPE="REFERENCE">Furukawa 2006</LINK>), whether this procedure was valid in our study sample was not confirmed. Thirdly, while this review included studies on the treatment of depression among advanced cancer patients, the results may not be applicable to advanced cancer patients with clinically diagnosed depression. Additionally, although this study also included meta-analyses for anxiety and general psychological distress, these findings were subsidiary and inconclusive. Finally, because the subjects' physical status (e.g., physical functioning, estimated survival) were not clearly defined <I>a priori </I>and the participants were at least not critically terminally ill (i.e. an estimated survival period of less than a few months), the findings may not be applicable to end-stage cancer patients who are nearing death.</P>
<P>Despite these limitations, the obtained findings about the usefulness of psychotherapy for ameliorating depression in advanced cancer patients deserve important consideration, and future studies to investigate and clarify the usefulness of psychotherapy for treating clinically diagnosed depression in terminally ill patients are warranted.</P>
</SUBSECTION>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>Evidence from RCTs of moderate quality suggests that psychotherapy is useful for treating depressive states in advanced cancer patients although little evidence supports the effectiveness of psychotherapy for patients with clinically diagnosed depression including major depressive disorder. The effects of psychotherapy are almost comparable to those observed in antidepressant pharmacotherapy studies of major depressive disorders in general psychiatry settings. Regarding the types of verbal and interactive psychotherapeutic interventions, the most common approach was long-term continuous supportive therapy, typically until the patients' deaths. Although our review could not clarify the cost effectiveness of psychotherapeutic interventions for patients with advanced cancer and considering that long-term continuous interventions requiring trained mental health professionals may not be easy to provide for all patients, our findings suggest that psychological interventions should be combined with routine patient care for the treatment of patients with advanced cancer. </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>The continuing effects of the completed interventions and the effectiveness of psychotherapy for the treatment of clinical depression should be addressed in future studies. In addition, clarifying the cost-effectiveness of psychotherapy and developing cost-effective interventions for the treatment of depression among advanced cancer patients are also important future tasks. Specific types of psychotherapy, especially cognitive behavioural therapy, are widely recommended for the treatment of psychological distress among cancer patients; however, our systematic review highlights the need for more well-designed clinical trials to clarify the effectiveness of cognitive behavioural therapy on depression in patients with advanced cancer. The effectiveness of psychotherapy for treating depression in end-stage cancer patients who are nearing death should also be investigated. Finally, given the difficulty of conducting clinical trials in palliative care settings and of evaluating the quality of clinical trials for psychological interventions, novel and realistic quality assessment systems may be needed for studies focusing on patients with advanced cancer.<BR/>
</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>This systematic review was conducted within the framework of the Cochrane Pain, Palliative and Supportive Care Review Group, and we acknowledge their help and support. This study was supported in part by a Grant-in-Aid from the Cancer Research and Second-Term Comprehensive Ten-Year Strategy for Cancer Control from the Ministry of Labour, Health and Welfare of Japan.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>T Akechi, J Onishi, T Morita, and TA Furukawa: conceptualized and designed the study. <BR/>T Akechi, T Okuyama, and J Onishi: conducted the systematic review. <BR/>T Akechi: conducted the statistical analysis of the study. <BR/>TA Furukawa: supervised the process of the systematic review. <BR/>All authors: interpreted the data and wrote the report.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2016-10-14 10:40:18 +0100" MODIFIED_BY="Anna Erskine">
<P>This review is correct at the date of publication. This review has now been stabilised following discussion with the editors and authors. If appropriate, we will update the review if new evidence likely to change the conclusions is published, or if standards change substantially which necessitate major revisions.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-10-14 10:42:03 +0100" MODIFIED_BY="Anna Erskine">
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Classen-2001" NAME="Classen 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Classen C, Butler LD, Koopman C, Miller E, DiMiceli S, Giese-Davis J, et al</AU>
<TI>Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2001</YR>
<VL>58</VL>
<NO>5</NO>
<PG>494-501</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291257"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291256"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Edelman-1999" NAME="Edelman 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edelman S, Bell DR, Kidman AD</AU>
<TI>A group cognitive behaviour therapy programme with metastatic breast cancer patients</TI>
<SO>Psychooncology</SO>
<YR>1999</YR>
<VL>8</VL>
<NO>4</NO>
<PG>295-305</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4397075"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291258"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goodwin-2001" NAME="Goodwin 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goodwin PJ, Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H, et al</AU>
<TI>The effect of group psychosocial support on survival in metastatic breast cancer</TI>
<SO>New England Journal of Medicine</SO>
<YR>2001</YR>
<VL>345</VL>
<NO>24</NO>
<PG>1719-26</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291261"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291260"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laidlaw-2005" NAME="Laidlaw 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laidlaw T, Bennett BM, Dwivedi P, Naito A, Gruzelier J</AU>
<TI>Quality of life and mood changes in metastatic breast cancer after training in self-hypnosis or johrei: a short report</TI>
<SO>Contemporary Hypnosis</SO>
<YR>2005</YR>
<VL>22</VL>
<NO>2</NO>
<PG>84-93</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4397076"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291288"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Linn-1982" NAME="Linn 1982" YEAR="1982">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Linn MW, Linn BS, Harris R</AU>
<TI>Effects of counseling for late stage cancer patients</TI>
<SO>Cancer</SO>
<YR>1982</YR>
<VL>49</VL>
<NO>5</NO>
<PG>1048-55</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291269"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291268"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liossi-2001" NAME="Liossi 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liossi C, White P</AU>
<TI>Efficacy of clinical hypnosis in the enhancement of quality of life of terminally ill cancer patients</TI>
<SO>Contemporary Hypnosis</SO>
<YR>2001</YR>
<VL>18</VL>
<NO>3</NO>
<PG>145-60</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291291"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291290"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sloman-2002" NAME="Sloman 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sloman R</AU>
<TI>Relaxation and imagery for anxiety and depression control in community patients with advanced cancer</TI>
<SO>Cancer Nursing</SO>
<YR>2002</YR>
<VL>25</VL>
<NO>6</NO>
<PG>432-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291311"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291310"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spiegel-1981" NAME="Spiegel 1981" YEAR="1981">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Spiegel D, Bloom JR, Yalom I</AU>
<TI>Group support for patients with metastatic cancer. A randomized outcome study</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1981</YR>
<VL>38</VL>
<NO>5</NO>
<PG>527-33</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291275"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291274"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wood-1997" NAME="Wood 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wood BC, Mynors-Wallis LM</AU>
<TI>Problem-solving therapy in palliative care</TI>
<SO>Palliative Medicine</SO>
<YR>1997</YR>
<VL>11</VL>
<NO>1</NO>
<PG>49-54</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291277"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291276"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wu-2003" NAME="Wu 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wu L, Wang S</AU>
<TI>Psychotherapy improving depression and anxiety of patients treated with chemotherapy combined with radiotherapy</TI>
<SO>Chinese Journal of Clinical Rehabilitation</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>17</NO>
<PG>2462-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291317"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291316"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Edmonds-1999" NAME="Edmonds 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edmonds CV, Lockwood GA, Cunningham AJ</AU>
<TI>Psychological response to long-term group therapy: a randomized trial with metastatic breast cancer patients</TI>
<SO>Psychooncology</SO>
<YR>1999</YR>
<VL>8</VL>
<NO>1</NO>
<PG>74-91</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4397077"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291282"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Giasson-1998" NAME="Giasson 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Giasson M, Bouchard L</AU>
<TI>Effect of therapeutic touch on the well-being of persons with terminal cancer</TI>
<SO>Journal of Holistic Nursing</SO>
<YR>1998</YR>
<VL>16</VL>
<NO>3</NO>
<PG>383-98</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291285"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291284"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mantovani-1996" NAME="Mantovani 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mantovani G, Astara G, Lampis B, Bianchi A, Curreli L, Orru W, et al</AU>
<TI>Evaluation by multidimensional instruments of health-related quality of life of elderly cancer patients undergoing three different "psychosocial" treatment approaches. A randomized clinical trial</TI>
<SO>Supportive Care in Cancer</SO>
<YR>1996</YR>
<VL>4</VL>
<NO>2</NO>
<PG>129-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291295"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291294"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-North-1992" NAME="North 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>North N, Cornbleet MA, Knowles G, Leonard RC</AU>
<TI>Information giving in oncology: a preliminary study of tape-recorder use</TI>
<SO>British Journal of Clinical Psychology</SO>
<YR>1992</YR>
<VL>31</VL>
<NO>Pt 3</NO>
<PG>357-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291301"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291300"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sarna-1998" NAME="Sarna 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sarna L</AU>
<TI>Effectiveness of structured nursing assessment of symptom distress in advanced lung cancer</TI>
<SO>Oncology Nursing Forum</SO>
<YR>1998</YR>
<VL>25</VL>
<NO>6</NO>
<PG>1041-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291305"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291304"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schofield-2003" NAME="Schofield 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schofield P, Payne S</AU>
<TI>A pilot study into the use of a multisensory environment (Snoezelen) within a palliative day-care setting</TI>
<SO>International Journal of Palliative Nursing</SO>
<YR>2003</YR>
<VL>9</VL>
<NO>3</NO>
<PG>124-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291307"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291306"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Soden-2004" NAME="Soden 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Soden K, Vincent K, Craske S, Lucas C, Ashley S</AU>
<TI>A randomized controlled trial of aromatherapy massage in a hospice setting</TI>
<SO>Palliative Medicine</SO>
<YR>2004</YR>
<VL>18</VL>
<NO>2</NO>
<PG>87-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291313"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291312"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES>
<REFERENCE ID="REF-Akechi-2001" NAME="Akechi 2001" TYPE="JOURNAL_ARTICLE">
<AU>Akechi T, Okamura H, Nishiwaki Y, Uchitomi Y</AU>
<TI>Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma: a longitudinal study</TI>
<SO>Cancer</SO>
<YR>2001</YR>
<VL>92</VL>
<NO>10</NO>
<PG>2609-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Alderson-2004" NAME="Alderson 2004" TYPE="BOOK">
<AU>Alderson P, Green S, Higgins JPT</AU>
<SO>Cochrane Reviewers' Handbook 4.2.2</SO>
<YR>2004</YR>
<PB>Wiley-Blackwell</PB>
<CY>Chichester, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Banerjee-2006" NAME="Banerjee 2006" TYPE="CONFERENCE_PROC">
<AU>Banerjee S, Wells G</AU>
<TI>Caveats in the meta-analysis of continuous data: a simulation study</TI>
<SO>XIVth Cochrane Colloquium</SO>
<YR>2006</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bech-2000" NAME="Bech 2000" TYPE="JOURNAL_ARTICLE">
<AU>Bech P, Cialdella P, Haugh MC, Birkett MA, Hours A, Boissel JP, et al</AU>
<TI>Meta-analysis of randomised controlled trials of fluoxetine versus placebo and tricyclic antidepressants in the short-term treatment of major depression</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2000</YR>
<VL>176</VL>
<PG>421-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Block-2000" NAME="Block 2000" TYPE="JOURNAL_ARTICLE">
<AU>Block SD</AU>
<TI>Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians - American Society of Internal Medicine</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2000</YR>
<VL>132</VL>
<NO>3</NO>
<PG>209-18</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bukberg-1984" NAME="Bukberg 1984" TYPE="JOURNAL_ARTICLE">
<AU>Bukberg J, Penman D, Holland JC</AU>
<TI>Depression in hospitalized cancer patients</TI>
<SO>Psychosomatic Medicine</SO>
<YR>1984</YR>
<VL>46</VL>
<NO>3</NO>
<PG>199-212</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cassileth-1985" NAME="Cassileth 1985" TYPE="JOURNAL_ARTICLE">
<AU>Cassileth BR, Lusk EJ, Strouse TB, Miller DS, Brown LL, Cross PA</AU>
<TI>A psychological analysis of cancer patients and their next-of-kin</TI>
<SO>Cancer</SO>
<YR>1985</YR>
<VL>55</VL>
<NO>1</NO>
<PG>72-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chan-2005" NAME="Chan 2005" TYPE="JOURNAL_ARTICLE">
<AU>Chan AW, Altman DG</AU>
<TI>Epidemiology and reporting of randomised trials published in PubMed journals</TI>
<SO>Lancet</SO>
<YR>2005</YR>
<VL>365</VL>
<PG>1159-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Colleoni-2000" NAME="Colleoni 2000" TYPE="JOURNAL_ARTICLE">
<AU>Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A</AU>
<TI>Depression and degree of acceptance of adjuvant cytotoxic drugs</TI>
<SO>Lancet</SO>
<YR>2000</YR>
<VL>356</VL>
<NO>9238</NO>
<PG>1326-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Derogatis-1983" NAME="Derogatis 1983" TYPE="JOURNAL_ARTICLE">
<AU>Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, et al</AU>
<TI>The prevalence of psychiatric disorders among cancer patients</TI>
<SO>Jounal of American Medical Association</SO>
<YR>1983</YR>
<VL>249</VL>
<NO>6</NO>
<PG>751-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Devine-1995" NAME="Devine 1995" TYPE="JOURNAL_ARTICLE">
<AU>Devine EC, Westlake SK</AU>
<TI>The effects of psychoeducational care provided to adults with cancer: meta-analysis of 116 studies</TI>
<SO>Oncology Nursing Forum</SO>
<YR>1995</YR>
<VL>22</VL>
<NO>9</NO>
<PG>1369-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Furukawa-2002" NAME="Furukawa 2002" TYPE="JOURNAL_ARTICLE">
<AU>Furukawa TA, Guyatt GH, Griffith LE</AU>
<TI>Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2002</YR>
<VL>31</VL>
<NO>1</NO>
<PG>72-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Furukawa-2006" NAME="Furukawa 2006" TYPE="JOURNAL_ARTICLE">
<AU>Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N</AU>
<TI>Imputing missing standard deviations in meta-analyses can provide accurate results</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2006</YR>
<VL>59</VL>
<PG>7-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Furukawa-2007" NAME="Furukawa 2007" TYPE="JOURNAL_ARTICLE">
<AU>Furukawa TA, Watanabe N, Omori I, Montori, VM, Guyatt G</AU>
<TI>Association between unreported outcomes and effect size estimates in Cochrane meta-analyses</TI>
<SO>Journal of American Medical Association</SO>
<YR>2007</YR>
<VL>297</VL>
<PG>468-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grassi-1996" NAME="Grassi 1996" TYPE="JOURNAL_ARTICLE">
<AU>Grassi L, Indelli M, Marzola M, Maestri A, Santini A, Piva E, et al</AU>
<TI>Depressive symptoms and quality of life in home-care-assisted cancer patients</TI>
<SO>Journal of Pain and Symptom Management</SO>
<YR>1996</YR>
<VL>12</VL>
<NO>5</NO>
<PG>300-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Henriksson-1995" NAME="Henriksson 1995" TYPE="JOURNAL_ARTICLE">
<AU>Henriksson MM, Isometsa ET, Hietanen PS, Aro HM, Lonnqvist JK</AU>
<TI>Mental disorders in cancer suicides</TI>
<SO>Journal of Affective Disorders</SO>
<YR>1995</YR>
<VL>36</VL>
<NO>1-2</NO>
<PG>11-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kugaya-2000" NAME="Kugaya 2000" TYPE="JOURNAL_ARTICLE">
<AU>Kugaya A, Akechi T, Okuyama T, Nakano T, Mikami I, Okamura H, et al</AU>
<TI>Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer</TI>
<SO>Cancer</SO>
<YR>2000</YR>
<VL>88</VL>
<NO>12</NO>
<PG>2817-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-MaNair-1992" NAME="MaNair 1992" TYPE="BOOK">
<AU>McNair DM, Lorr M, Droppleman LF</AU>
<SO>Edits manual for the Profile of Mood States</SO>
<YR>1992</YR>
<PB>Edits/Educational and Industrial Testing Service</PB>
<CY>San Diego</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McDaniel-1995" NAME="McDaniel 1995" TYPE="JOURNAL_ARTICLE">
<AU>McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB</AU>
<TI>Depression in patients with cancer. Diagnosis, biology, and treatment</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1995</YR>
<VL>52</VL>
<NO>2</NO>
<PG>89-99</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Newell-2002" NAME="Newell 2002" TYPE="JOURNAL_ARTICLE">
<AU>Newell SA, Sanson-Fisher RW, Savolainen NJ</AU>
<TI>Systematic review of psychological therapies for cancer patients: overview and recommendations for future research</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>2002</YR>
<VL>94</VL>
<NO>8</NO>
<PG>558-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Okamura-2000" NAME="Okamura 2000" TYPE="JOURNAL_ARTICLE">
<AU>Okamura H, Watanabe T, Narabayashi M, Katsumata N, Ando M, Adachi I, et al</AU>
<TI>Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors</TI>
<SO>Breast Cancer Research and Treatment</SO>
<YR>2000</YR>
<VL>61</VL>
<NO>2</NO>
<PG>131-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Okuyama-2007" NAME="Okuyama 2007" TYPE="JOURNAL_ARTICLE">
<AU>Okuyama T, Nakane Y, Endo C, Seto T, Kato M, Seki N, et al</AU>
<TI>Mental health literacy in Japanese cancer patients: ability to recognize depression and preferences of treatments-comparison with Japanese lay public</TI>
<SO>Psychooncology</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>9</NO>
<PG>834-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Oxman-1992" NAME="Oxman 1992" TYPE="JOURNAL_ARTICLE">
<AU>Oxman AD, Guyatt GH</AU>
<TI>A consumer's guide to subgroup analyses</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1992</YR>
<VL>116</VL>
<NO>1</NO>
<PG>78-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Penrod-2004" NAME="Penrod 2004" TYPE="JOURNAL_ARTICLE">
<AU>Penrod JD, Morrison RS</AU>
<TI>Challenges for palliative care research</TI>
<SO>Journal of Palliative Medicine</SO>
<YR>2004</YR>
<VL>7</VL>
<PG>398-402</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Prieto-2002" NAME="Prieto 2002" TYPE="JOURNAL_ARTICLE">
<AU>Prieto JM, Blanch J, Atala J, Carreras E, Rovira M, Cirera E, et al</AU>
<TI>Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2002</YR>
<VL>20</VL>
<NO>7</NO>
<PG>1907-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ross-2002" NAME="Ross 2002" TYPE="JOURNAL_ARTICLE">
<AU>Ross L, Boesen EH, Dalton SO, Johansen C</AU>
<TI>Mind and cancer: does psychosocial intervention improve survival and psychological well-being?</TI>
<SO>European Journal of Cancer</SO>
<YR>2002</YR>
<VL>38</VL>
<NO>11</NO>
<PG>1447-57</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sheard-1999" NAME="Sheard 1999" TYPE="JOURNAL_ARTICLE">
<AU>Sheard T, Maguire P</AU>
<TI>The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses</TI>
<SO>British Journal of Cancer</SO>
<YR>1999</YR>
<VL>80</VL>
<NO>11</NO>
<PG>1770-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spiegel-1978" NAME="Spiegel 1978" TYPE="JOURNAL_ARTICLE">
<AU>Spiegel D, Yalom ID</AU>
<TI>A support group for dying patients</TI>
<SO>International Journal of Group Psychotherapy</SO>
<YR>1978</YR>
<VL>28</VL>
<PG>233-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-SPSS-2003" NAME="SPSS 2003" TYPE="COMPUTER_PROGRAM">
<TI>SPSS</TI>
<YR>2003</YR>
<EN>11.5.1 J for Windows</EN>
<PB>SPSS Japan Inc</PB>
<CY>Tokyo, Japan</CY>
<MD>CD-ROM</MD>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Williams-2006" NAME="Williams 2006" TYPE="JOURNAL_ARTICLE">
<AU>Williams S, Dale J</AU>
<TI>The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review</TI>
<SO>British Journal of Cancer</SO>
<YR>2006</YR>
<VL>94</VL>
<PG>372-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yalom-1977" NAME="Yalom 1977" TYPE="JOURNAL_ARTICLE">
<AU>Yalom ID, Greaves C</AU>
<TI>Group therapy with the terminally ill</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1977</YR>
<VL>134</VL>
<PG>396-400</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES>
<REFERENCE ID="REF-Barsevick-2002" NAME="Barsevick 2002" TYPE="JOURNAL_ARTICLE">
<AU>Barsevick AM, Sweeney C, Haney E, Chung E</AU>
<TI>A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer</TI>
<SO>Oncology Nursing Forum</SO>
<YR>2002</YR>
<VL>29</VL>
<NO>1</NO>
<PG>73-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Edwards-2004" NAME="Edwards 2004" TYPE="COCHRANE_REVIEW">
<AU>Edwards AG, Hailey S, Maxwell M</AU>
<TI>Psychological interventions for women with metastatic breast cancer</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>CD004253</NO>
<PB>Wiley-Blackwell</PB>
<CY>Chichester, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Luebbert-2001" NAME="Luebbert 2001" TYPE="JOURNAL_ARTICLE">
<AU>Luebbert K, Dahme B, Hasenbring M</AU>
<TI>The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review</TI>
<SO>Psychooncology</SO>
<YR>2001</YR>
<VL>10</VL>
<NO>6</NO>
<PG>490-502</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Meyer-1995" NAME="Meyer 1995" TYPE="JOURNAL_ARTICLE">
<AU>Meyer TJ, Mark MM</AU>
<TI>Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments</TI>
<SO>Health Psychology</SO>
<YR>1995</YR>
<VL>14</VL>
<NO>2</NO>
<PG>101-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rehse-2003" NAME="Rehse 2003" TYPE="JOURNAL_ARTICLE">
<AU>Rehse B, Pukrop R</AU>
<TI>Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies</TI>
<SO>Patient Education and Counseling</SO>
<YR>2003</YR>
<VL>50</VL>
<NO>2</NO>
<PG>179-86</PG>
<IDENTIFIERS/>
</REFERENCE>
</PENDING_REFERENCES>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Classen-2001">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>125 women with metastatic breast cancer; American</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Supportive-expressive group psychotherapy, including fostering support among group members and encouraging the expression of emotions, psychoeducation, and self-hypnosis exercise<BR/>(90 minutes weekly session lasting at least one year)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Profile of Mood States, Impact of Event scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Quality score: 10<BR/>It is reported that the group therapy did not improve depression</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Edelman-1999">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>124 women with metastatic breast cancer; Australian</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group cognitive behavior therapy<BR/>(8 weekly sessions)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Profile of Mood States, Coopersmith Self-esteem Inventory</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Quality score: 7<BR/>It is reported that the therapy improved depression</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Goodwin-2001">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>235 women with metastatic breast cancer; Canadian</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Supportive-expressive group psychotherapy, including fostering support among group members and encouraging the expression of emotions about cancer and its effects on their lives (90 minutes weekly session lasting at least one year)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Profile of Mood States, Pain scale, Suffering scale, Survival</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Quality score: 17<BR/>It is reported that the group therapy improved depression</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Laidlaw-2005">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>37 women with metastatic breast cancer; English</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. Self -hypnosis, including both anti-stress and anxiety techniques and visualization techniques (four weeks)<BR/>2. Johrei, a healing technique developed in Japan, is non-touch, and requires the practitioner to visualize healing light entering the body and being transferred via the outstretched hand to the recipient with a spirit of goodwill towards the other person (four weeks)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Beck Depression Inventory, Profile of Mood States Bi-Polar-Form, State Trait Anxiety Inventory, Impact of Event Scale, EORTC QLQ-C30, BR23<BR/>(Assessment was conducted after at least three months of practice)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Quality score: 5<BR/>The statistical results regarding depression were not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Linn-1982">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>One hundred and twenty men with end-stage cancer (clinical stage IV) identified on wards of a large general hospital; American</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Counseling, including reducing denial, maintaining hope, life review, support for families <BR/>(several times a week till death)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Profile of Mood States, life satisfaction, self-esteem, alienation, locus of control <BR/>(one, three, six, nine, 12 months after the treatment)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Quality score: 13<BR/>It is reported that the therapy improved depression at three months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Liossi-2001">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Fifty terminally ill cancer patients who were referred for palliative care; Greek</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Hypnosis, including induction, suggestions for symptom management and ego-strengthening, and post hypnotic suggestions for comfort and maintenance of the therapeutic benefits<BR/>(30-minutes four weekly sessions)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Hospital Anxiety and Depression scale, Rotterdam Symptom Checklist<BR/>(four weeks after the start of the treatment)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Quality score: 9<BR/>It is reported that the therapy improved depression</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sloman-2002">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Fifty six advanced cancer patients receiving home palliative care who were experiencing anxiety and depression; Australian</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Progressive muscle relaxation and guided imagery<BR/>(twice weekly)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Hospital Anxiety and Depression scale, Functional Living Index-Cancer scale<BR/>(three weeks after the initial session)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Quality score: 4<BR/>It is reported that significant positive changes occurred for depression</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Spiegel-1981">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eighty six women with metastatic breast cancer; American</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Psychological support group, including fostering support among group members and encouraging the expression of emotions (90 minutes weekly session lasting at least one year)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Profile of Mood States, Rotter Internal/External Locus of Control Scale, Health Locus of Control Scale, Self-esteem (from the Janis-Field Scale), Maladaptive coping response, Phobias, Denial</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Quality score: 9<BR/>The original study revealed "The treatment group tended (although not significantly) to be less depressed" on the basis of the findings about slopes analysis that investigated the score change per 100 days. On the other hand, because we set the outcome at the end of the study in the protocol, we recalculated the score change during 300 days. Consequently the score change has become to be statistically significant.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wood-1997">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Twenty cancer patients who were referred to hospice home care teams; English</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Problem-solving therapy <BR/>(three to five sessions)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Profile of Mood States, Hospital Anxiety and Depression scale, modified Social Adjustment Scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Quality score: 9<BR/>The statistical results regarding depression were not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wu-2003">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>One hundred and twenty lung cancer patients receiving chemotherapy combined with radiotherapy; Chinese</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Supporting psychotherapy, including cognitive therapy, patient self-help group, behavioral therapy, and family education</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Self-Rating Depression Scale, Self-Rating Anxiety Scale<BR/>(one month after the start of the treatment )</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Quality score: 12<BR/>It is reported that the patients of the treatment group made a significant progress in relieving the depression compared with the control group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Edmonds-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Although the POMS-Short Form was used as a psychological measure, this questionnaire cannot assess depression</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Giasson-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>The intervention (noncontact therapeutic touch) was not considered as psychotherapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mantovani-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>The study did not include the usual care in the control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-North-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>The intervention (information giving by tape-recording the consultation) was not considered as psychotherapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sarna-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>The intervention (structured nursing assessment of symptom) was not considered as psychotherapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schofield-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>The intervention (use of multisensory environment [Snoezelen]) was not considered as psychotherapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Soden-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>The intervention (aromatherapy, including massages with lavender essential oil and an inert oil) was not considered as psychotherapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Classen-2001">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Edelman-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Goodwin-2001">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Laidlaw-2005">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Linn-1982">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liossi-2001">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sloman-2002">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Spiegel-1981">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wood-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wu-2003">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-11-07 00:11:54 +0000" MODIFIED_BY="Jessica R Thomas"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Psychotherapy versus treatment as usual</NAME>
<CONT_OUTCOME CHI2="17.288288700761356" CI_END="-0.07996217128687455" CI_START="-0.8003977790984014" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.44017997519263796" ESTIMABLE="YES" I2="71.0786875060699" I2_Q="0.0" ID="CMP-001.01" NO="1" P_CHI2="0.003984295913893154" P_Q="1.0" P_Z="0.01661844536206768" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="USER" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.13147984637899707" TOTALS="YES" TOTAL_1="292" TOTAL_2="225" UNITS="" WEIGHT="100.0" Z="2.395042356981904">
<NAME>Depression</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.14098957999098305" CI_START="-0.8518646017786704" EFFECT_SIZE="-0.4964270908848267" ESTIMABLE="YES" MEAN_1="-1.7" MEAN_2="2.6" ORDER="2" SD_1="9.2" SD_2="7.1" SE="0.1813490011538423" STUDY_ID="STD-Goodwin-2001" TOTAL_1="102" TOTAL_2="45" WEIGHT="20.550326567189074"/>
<CONT_DATA CI_END="0.34302229739134066" CI_START="-0.44077544021433473" EFFECT_SIZE="-0.048876571411497045" ESTIMABLE="YES" MEAN_1="-1.8" MEAN_2="-1.44" ORDER="3" SD_1="7.94" SD_2="6.38" SE="0.1999520766167572" STUDY_ID="STD-Classen-2001" TOTAL_1="58" TOTAL_2="44" WEIGHT="19.700154233134544"/>
<CONT_DATA CI_END="-0.14481443404847982" CI_START="-0.9806133233815268" EFFECT_SIZE="-0.5627138787150033" ESTIMABLE="YES" MEAN_1="-3.07" MEAN_2="1.22" ORDER="4" SD_1="7.91" SD_2="7.24" SE="0.21321792031020007" STUDY_ID="STD-Edelman-1999" TOTAL_1="43" TOTAL_2="49" WEIGHT="19.08991093998931"/>
<CONT_DATA CI_END="2.0799418040038304" CI_START="-0.896285039633026" EFFECT_SIZE="0.5918283821854022" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="-2.0" ORDER="5" SD_1="2.77" SD_2="4.0" SE="0.759255493241956" STUDY_ID="STD-Wood-1997" TOTAL_1="5" TOTAL_2="3" WEIGHT="4.771251910076467"/>
<CONT_DATA CI_END="0.18809234101230143" CI_START="-0.576463229141377" EFFECT_SIZE="-0.1941854440645378" ESTIMABLE="YES" MEAN_1="-1.0" MEAN_2="0.4" ORDER="6" SD_1="7.94" SD_2="6.38" SE="0.195043270229554" STUDY_ID="STD-Linn-1982" TOTAL_1="50" TOTAL_2="56" WEIGHT="19.92548067010484"/>
<CONT_DATA CI_END="-0.7648811848631586" CI_START="-1.8744614085373317" EFFECT_SIZE="-1.319671296700245" ESTIMABLE="YES" MEAN_1="-0.12" MEAN_2="2.52" ORDER="7" SD_1="1.75" SD_2="2.22" SE="0.28306138082801524" STUDY_ID="STD-Spiegel-1981" TOTAL_1="34" TOTAL_2="28" WEIGHT="15.962875679505766"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="36.77201024851021" CI_END="0.014365969004243584" CI_START="-1.366354468901755" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6759942499487558" ESTIMABLE="YES" I2="89.12216119551948" I2_Q="0.0" ID="CMP-001.02" NO="2" P_CHI2="2.0070156359075497E-7" P_Q="1.0" P_Z="0.05496176689673466" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="USER" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.5076194892984927" TOTALS="YES" TOTAL_1="242" TOTAL_2="169" UNITS="" WEIGHT="99.99999999999999" Z="1.9191783467261623">
<NAME>Anxiety</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.15987226372406205" CI_START="-0.8714828603369728" EFFECT_SIZE="-0.5156775620305174" ESTIMABLE="YES" MEAN_1="-1.5" MEAN_2="1.9" ORDER="2" SD_1="6.9" SD_2="5.7" SE="0.1815366512410443" STUDY_ID="STD-Goodwin-2001" TOTAL_1="102" TOTAL_2="45" WEIGHT="22.95087990335155"/>
<CONT_DATA CI_END="0.34849961187472683" CI_START="-0.43527280910259386" EFFECT_SIZE="-0.0433865986139335" ESTIMABLE="YES" MEAN_1="-0.6" MEAN_2="-0.36" ORDER="3" SD_1="5.8" SD_2="5.05" SE="0.19994561817452194" STUDY_ID="STD-Classen-2001" TOTAL_1="58" TOTAL_2="44" WEIGHT="22.656545200973902"/>
<CONT_DATA CI_END="0.08329436221434439" CI_START="-0.7415600163204437" EFFECT_SIZE="-0.32913282705304964" ESTIMABLE="YES" MEAN_1="-1.53" MEAN_2="0.29" ORDER="4" SD_1="5.2" SD_2="5.72" SE="0.21042590196583563" STUDY_ID="STD-Edelman-1999" TOTAL_1="43" TOTAL_2="49" WEIGHT="22.47998830288827"/>
<CONT_DATA CI_END="1.4061360807903474" CI_START="-1.4567865234120938" EFFECT_SIZE="-0.025325221310873267" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.33" ORDER="5" SD_1="4.09" SD_2="5.13" SE="0.7303508193989301" STUDY_ID="STD-Wood-1997" TOTAL_1="5" TOTAL_2="3" WEIGHT="11.917669406341385"/>
<CONT_DATA CI_END="-1.6961439997214542" CI_START="-3.013098915441965" EFFECT_SIZE="-2.3546214575817097" ESTIMABLE="YES" MEAN_1="-2.73" MEAN_2="0.87" ORDER="6" SD_1="1.28" SD_2="1.75" SE="0.33596406008183904" STUDY_ID="STD-Spiegel-1981" TOTAL_1="34" TOTAL_2="28" WEIGHT="19.994917186444887"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="52.912690574853464" CI_END="-0.013397423300820055" CI_START="-1.8731254814533695" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.9432614523770948" ESTIMABLE="YES" I2="94.3302826459826" I2_Q="0.0" ID="CMP-001.03" NO="3" P_CHI2="1.913680325316136E-11" P_Q="1.0" P_Z="0.046789240666148306" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.8356099010377059" TOTALS="YES" TOTAL_1="237" TOTAL_2="166" UNITS="" WEIGHT="100.0" Z="1.9882030241567714">
<NAME>Total Mood Disturbance</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.03129565333761347" CI_START="-0.7384472889967455" EFFECT_SIZE="-0.3848714711671795" ESTIMABLE="YES" MEAN_1="-1.8" MEAN_2="9.7" ORDER="1" SD_1="31.7" SD_2="24.6" SE="0.18039914029978457" STUDY_ID="STD-Goodwin-2001" TOTAL_1="102" TOTAL_2="45" WEIGHT="25.926629858516367"/>
<CONT_DATA CI_END="0.3589315623531651" CI_START="-0.42480098682223316" EFFECT_SIZE="-0.03293471223453404" ESTIMABLE="YES" MEAN_1="-2.52" MEAN_2="-1.68" ORDER="2" SD_1="27.38" SD_2="22.28" SE="0.19993544660957563" STUDY_ID="STD-Classen-2001" TOTAL_1="58" TOTAL_2="44" WEIGHT="25.706612733133877"/>
<CONT_DATA CI_END="-0.025497671325181548" CI_START="-0.8548576825678408" EFFECT_SIZE="-0.44017767694651116" ESTIMABLE="YES" MEAN_1="-9.4" MEAN_2="2.06" ORDER="3" SD_1="26.44" SD_2="25.26" SE="0.2115753191855935" STUDY_ID="STD-Edelman-1999" TOTAL_1="43" TOTAL_2="49" WEIGHT="25.56674837189582"/>
<CONT_DATA CI_END="-2.405616225332114" CI_START="-3.9318526017929116" EFFECT_SIZE="-3.168734413562513" ESTIMABLE="YES" MEAN_1="-7.35" MEAN_2="14.94" ORDER="4" SD_1="5.66" SD_2="8.25" SE="0.3893531688591106" STUDY_ID="STD-Spiegel-1981" TOTAL_1="34" TOTAL_2="28" WEIGHT="22.800009036453943"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Subgroup analyses</NAME>
<CONT_OUTCOME CHI2="13.561915287740916" CI_END="-0.12696599061447356" CI_START="-1.0236844198300097" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5753252052222416" ESTIMABLE="YES" I2="77.8792306517959" I2_Q="0.0" ID="CMP-002.01" NO="1" P_CHI2="0.0035663840054495077" P_Q="1.0" P_Z="0.011903746160148755" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.1611601184241744" TOTALS="YES" TOTAL_1="237" TOTAL_2="166" UNITS="" WEIGHT="100.00000000000001" Z="2.514984960485682">
<NAME>Depression</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.14098957999098305" CI_START="-0.8518646017786704" EFFECT_SIZE="-0.4964270908848267" ESTIMABLE="YES" MEAN_1="-1.7" MEAN_2="2.6" ORDER="2" SD_1="9.2" SD_2="7.1" SE="0.1813490011538423" STUDY_ID="STD-Goodwin-2001" TOTAL_1="102" TOTAL_2="45" WEIGHT="26.967941009293394"/>
<CONT_DATA CI_END="0.34302229739134066" CI_START="-0.44077544021433473" EFFECT_SIZE="-0.048876571411497045" ESTIMABLE="YES" MEAN_1="-1.8" MEAN_2="-1.44" ORDER="3" SD_1="7.94" SD_2="6.38" SE="0.1999520766167572" STUDY_ID="STD-Classen-2001" TOTAL_1="58" TOTAL_2="44" WEIGHT="26.016898191441854"/>
<CONT_DATA CI_END="-0.14481443404847982" CI_START="-0.9806133233815268" EFFECT_SIZE="-0.5627138787150033" ESTIMABLE="YES" MEAN_1="-3.07" MEAN_2="1.22" ORDER="4" SD_1="7.91" SD_2="7.24" SE="0.21321792031020007" STUDY_ID="STD-Edelman-1999" TOTAL_1="43" TOTAL_2="49" WEIGHT="25.326749594575833"/>
<CONT_DATA CI_END="-0.7648811848631586" CI_START="-1.8744614085373317" EFFECT_SIZE="-1.319671296700245" ESTIMABLE="YES" MEAN_1="-0.12" MEAN_2="2.52" ORDER="7" SD_1="1.75" SD_2="2.22" SE="0.28306138082801524" STUDY_ID="STD-Spiegel-1981" TOTAL_1="34" TOTAL_2="28" WEIGHT="21.688411204688926"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="36.32524593212941" CI_END="-0.012350402021675255" CI_START="-1.5198698511023507" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.766110126562013" ESTIMABLE="YES" I2="91.74128096584607" I2_Q="0.0" ID="CMP-002.02" NO="2" P_CHI2="6.391721218967916E-8" P_Q="1.0" P_Z="0.04636248704114086" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.5357316545564993" TOTALS="YES" TOTAL_1="237" TOTAL_2="166" UNITS="" WEIGHT="100.0" Z="1.9920781216702066">
<NAME>Anxiety</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.15987226372406205" CI_START="-0.8714828603369728" EFFECT_SIZE="-0.5156775620305174" ESTIMABLE="YES" MEAN_1="-1.5" MEAN_2="1.9" ORDER="2" SD_1="6.9" SD_2="5.7" SE="0.1815366512410443" STUDY_ID="STD-Goodwin-2001" TOTAL_1="102" TOTAL_2="45" WEIGHT="26.007356638600424"/>
<CONT_DATA CI_END="0.34849961187472683" CI_START="-0.43527280910259386" EFFECT_SIZE="-0.0433865986139335" ESTIMABLE="YES" MEAN_1="-0.6" MEAN_2="-0.36" ORDER="3" SD_1="5.8" SD_2="5.05" SE="0.19994561817452194" STUDY_ID="STD-Classen-2001" TOTAL_1="58" TOTAL_2="44" WEIGHT="25.69011054212794"/>
<CONT_DATA CI_END="0.08329436221434439" CI_START="-0.7415600163204437" EFFECT_SIZE="-0.32913282705304964" ESTIMABLE="YES" MEAN_1="-1.53" MEAN_2="0.29" ORDER="4" SD_1="5.2" SD_2="5.72" SE="0.21042590196583563" STUDY_ID="STD-Edelman-1999" TOTAL_1="43" TOTAL_2="49" WEIGHT="25.499617019726436"/>
<CONT_DATA CI_END="-1.6961439997214542" CI_START="-3.013098915441965" EFFECT_SIZE="-2.3546214575817097" ESTIMABLE="YES" MEAN_1="-2.73" MEAN_2="0.87" ORDER="6" SD_1="1.28" SD_2="1.75" SE="0.33596406008183904" STUDY_ID="STD-Spiegel-1981" TOTAL_1="34" TOTAL_2="28" WEIGHT="22.802915799545204"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="52.912690574853464" CI_END="-0.013397423300819833" CI_START="-1.8731254814533693" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.9432614523770946" ESTIMABLE="YES" I2="94.3302826459826" I2_Q="0.0" ID="CMP-002.03" NO="3" P_CHI2="1.913680325316136E-11" P_Q="1.0" P_Z="0.04678924066614836" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.8356099010377059" TOTALS="YES" TOTAL_1="237" TOTAL_2="166" UNITS="" WEIGHT="100.0" Z="1.988203024156771">
<NAME>Total Mood Disturbance</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.03129565333761347" CI_START="-0.7384472889967455" EFFECT_SIZE="-0.3848714711671795" ESTIMABLE="YES" MEAN_1="-1.8" MEAN_2="9.7" ORDER="1" SD_1="31.7" SD_2="24.6" SE="0.18039914029978457" STUDY_ID="STD-Goodwin-2001" TOTAL_1="102" TOTAL_2="45" WEIGHT="25.926629858516367"/>
<CONT_DATA CI_END="0.3589315623531651" CI_START="-0.42480098682223316" EFFECT_SIZE="-0.03293471223453404" ESTIMABLE="YES" MEAN_1="-2.52" MEAN_2="-1.68" ORDER="2" SD_1="27.38" SD_2="22.28" SE="0.19993544660957563" STUDY_ID="STD-Classen-2001" TOTAL_1="58" TOTAL_2="44" WEIGHT="25.706612733133877"/>
<CONT_DATA CI_END="-0.025497671325181548" CI_START="-0.8548576825678408" EFFECT_SIZE="-0.44017767694651116" ESTIMABLE="YES" MEAN_1="-9.4" MEAN_2="2.06" ORDER="3" SD_1="26.44" SD_2="25.26" SE="0.2115753191855935" STUDY_ID="STD-Edelman-1999" TOTAL_1="43" TOTAL_2="49" WEIGHT="25.56674837189582"/>
<CONT_DATA CI_END="-2.405616225332114" CI_START="-3.9318526017929116" EFFECT_SIZE="-3.168734413562513" ESTIMABLE="YES" MEAN_1="-7.35" MEAN_2="14.94" ORDER="4" SD_1="5.66" SD_2="8.25" SE="0.3893531688591106" STUDY_ID="STD-Spiegel-1981" TOTAL_1="34" TOTAL_2="28" WEIGHT="22.800009036453943"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Sensitivity analyses</NAME>
<CONT_OUTCOME CHI2="1.287901682384652" CI_END="-0.058113755121148025" CI_START="-0.649552740116513" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3538332476188305" ESTIMABLE="YES" I2="22.354321476743415" I2_Q="0.0" ID="CMP-003.01" NO="1" P_CHI2="0.25643511623900106" P_Q="1.0" P_Z="0.019020486410031106" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="USER" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.010210337795652571" TOTALS="YES" TOTAL_1="152" TOTAL_2="101" UNITS="" WEIGHT="100.0" Z="2.345129216908776">
<NAME>Depression</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.14098957999098305" CI_START="-0.8518646017786704" EFFECT_SIZE="-0.4964270908848267" ESTIMABLE="YES" MEAN_1="-1.7" MEAN_2="2.6" ORDER="2" SD_1="9.2" SD_2="7.1" SE="0.1813490011538423" STUDY_ID="STD-Goodwin-2001" TOTAL_1="102" TOTAL_2="45" WEIGHT="52.82124592486035"/>
<CONT_DATA CI_END="0.18809234101230143" CI_START="-0.576463229141377" EFFECT_SIZE="-0.1941854440645378" ESTIMABLE="YES" MEAN_1="-1.0" MEAN_2="0.4" ORDER="6" SD_1="7.94" SD_2="6.38" SE="0.195043270229554" STUDY_ID="STD-Linn-1982" TOTAL_1="50" TOTAL_2="56" WEIGHT="47.17875407513964"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-01" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Funnel plot for the outcome depression</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAAAAAFUAAKoAAP8AJAAA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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-02" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Funnel plot for the outcome anxieety</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAAAAAFUAAKoAAP8AJAAA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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-03" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Funnel plot for the outcome total mood disturbance</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAAAAAFUAAKoAAP8AJAAA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-11-07 00:10:35 +0000" MODIFIED_BY="Jessica R Thomas">
<APPENDIX ID="APP-01" MODIFIED="2008-11-07 00:10:35 +0000" MODIFIED_BY="Jessica R Thomas" NO="1">
<TITLE MODIFIED="2008-11-07 00:10:35 +0000" MODIFIED_BY="Jessica R Thomas">MEDLINE via OVID search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-07 00:10:15 +0000" MODIFIED_BY="Jessica R Thomas">
<P>1. exp PSYCHOTHERAPY/<BR/>2. (psychotherap$ or aromatherap$ or "art therap$" or "autogenic training" or "behavior$ adj6 therap$" or (behaviour$ adj6 therap$) or (biofeedback and psycho$) or (cognitive adj6 therap$) or (desensiti$ and psychol$) or "implosive therap$" or (relax$ adj6 therap$) or (relax$ adj6 techniq$) or (therap$ adj6 touch$) or yoga)<BR/>3. (bibliotherapy or (color$ adj6 therap$) or (colour$ adj6 therap$) or (music$ adj6 therap$) or (hypno$ adj6 therap$) or (imagery and psychotherap$) or counsel$ or (group$ adj6 therap$) or "socioenvironmental therap$" or "socio environmental therap$" or "milieu therap$" or "therapeutic communit$" or (famil$ adj6 therap$) or psychosoc$ or psycholog$ or "self help group$" or (support$ adj6 group$) or (guide$ adj6 image$))<BR/>4. or/1-3<BR/>5. Depression/<BR/>6. (depression or depressive$ or depressed)<BR/>7. or/5-6<BR/>8. exp NEOPLASMS/<BR/>9. (tumor$ or tumour$ or cancer$ or carcinoma$ or malignan$ or neoplas$)<BR/>10. or/8-9<BR/>11. 4 and 7 and 10</P>
<P>The above search strategy was run with the following filter for Controlled Clinical Trials:<BR/>Cochrane Sensitive Search strategy for RCTs for MEDLINE on OVID (published in appendix 5b Cochrane Handbook for Systematic Reviews of Interventions. 4.2.5 May 2005)<BR/>1. randomized controlled trial.pt.<BR/>2. controlled clinical trial.pt.<BR/>3. randomized controlled trials.sh.<BR/>4. random allocation.sh.<BR/>5. double blind method.sh.<BR/>6. single blind method.sh.<BR/>7. or/1-6<BR/>8. (ANIMALS not HUMAN).sh.<BR/>9. 7 not 8<BR/>10. clinical trial.pt.<BR/>11. exp clinical trials/<BR/>12. (clin$ adj25 trial$).ti,ab.<BR/>13. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab.<BR/>14. placebos.sh.<BR/>15. placebo$.ti,ab.<BR/>16. random$.ti,ab.<BR/>17. research design.sh.<BR/>18. or/10-17<BR/>19. 18 not 8<BR/>20. 19 not 9<BR/>21. 9 or 19</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2008-11-07 00:09:59 +0000" MODIFIED_BY="Jessica R Thomas" NO="2">
<TITLE MODIFIED="2008-11-07 00:09:56 +0000" MODIFIED_BY="Jessica R Thomas">Other search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-07 00:09:59 +0000" MODIFIED_BY="Jessica R Thomas">
<TABLE COLS="2" ROWS="8">
<TR>
<TH>
<P>Database searched</P>
</TH>
<TH>
<P>Search strategy used</P>
</TH>
</TR>
<TR>
<TD>
<P>PaPaS TRIALS REGISTER<BR/>
<BR/>
</P>
</TD>
<TD>
<P>((psychotherapy OR psychotherapy* OR aromatherapy* OR "art therapy" OR "autogenic training" OR "behavior* therapy" OR "behaviour* therap*" OR (biofeedback AND psycho*) OR "cognitive therapy" OR "cognitive behavioural therap*" OR (desensiti* AND psychol*) OR "implosive therapy" OR "relaxation therap*" OR "relaxation technique*" OR "therapeutic touch" OR "touch therap*" OR yoga OR bibliotherapy OR "colour therap*" OR "colour therapy" OR "music therapy" OR hypnotherapy OR (imagery AND psychotherapy*) OR counsel* OR "group therap*" OR "socioenvironmental therapy" OR "socio-environmental therapy" OR "milieu therapy" OR "therapeutic community" OR "family therap*" OR psychosoc* OR psycholog* OR "self help group*" OR "support* group*" OR "guided imagery") AND (depression OR depressive$ OR depressed) AND (neoplasms OR tumor$ OR tumour$ OR cancer$ OR carcinoma$ OR malignan$ OR neoplas$))</P>
</TD>
</TR>
<TR>
<TD>
<P>CENTRAL<BR/>
</P>
</TD>
<TD>
<P>#1 PSYCHOTHERAPY (explode all trees MeSH)<BR/>#2 (psychotherap* or aromatherap* or (art next therap*) or (autogenic next training) or (behavior* near therap*) or (behaviour* near therap*) or (biofeedback and psycho*) or (cognitive near therap*) or (desensiti* and psychol*) or (implosive near therap*) or (relax* near therap*) or (relax* near techniq*) or (therap* near touch*) or yoga)<BR/>#3 (bibliotherapy or (color* near therap*) or (colour* near therap*) or (music* near therap*) or (hypno* near therap*) or (imagery AND psychotherap*) or counsel* or (group* NEAR therap*) or (socioenvironmental next therap*) or (socio next environmental next therap*) or (milieu next therap*) or (therapeutic communit*) or (famil* near therap*) or psychosoc* or psycholog* or self help group* or support* NEAR group* or guide* NEAR image*)<BR/>#4 (#1 or #2 or #3)<BR/>#5 DEPRESSION (single term MeSH)<BR/>#6 (depression or depressive* or depressed)<BR/>#7 (#5 or #6)<BR/>#8 NEOPLASMS (explode all trees MeSH)<BR/>#9 (tumor* or tumour* or cancer* or carcinoma* or malignan* or neoplas*)<BR/>#10 (#8 or #9)<BR/>#11 (#4 and #7 and #10)<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>EMBASE via Embase.Com</P>
</TD>
<TD>
<P>(('psychotherapy'/exp AND [embase]/lim) OR ((psychotherap* OR aromatherap* OR 'art therapy' OR 'autogenic training' OR 'behavior therapy' OR 'behavioural therapy' OR ('biofeedback' AND psycho*) OR 'cognitive therapy' OR 'cognitive behavioural therapy' OR 'cognitive behavioural therapies' OR (desensiti* AND psychol*) OR 'implosive therapy' OR 'relaxation therapy' OR 'relaxation therapies' OR 'relaxation technique' OR 'relaxation techniques' OR 'theraputic touch' OR 'touch therapy' OR 'touch teherapies' OR 'yoga') AND [embase]/lim AND [embase]/lim) OR ((bibliotherapy OR 'color therapy' OR 'colour therapy' OR 'color therapies' OR 'colour therapies' OR 'music therapy' OR 'hypnotherapy' AND imagery AND psychotherap* OR counsel* OR 'group therapy' OR 'group therapies' OR 'socioenvironmental therapy' OR 'socio environmental therapy' OR 'milieu therapy' OR 'theraputic community' OR 'family therapy' OR 'family therapies' OR psychosoc* OR psycholog* OR 'self help group' OR 'self help groups' OR 'support group' OR 'support groups' OR 'supportive group' OR 'supportive groups' OR 'guided imagery') AND [embase]/lim)) AND ((depression OR depressive* OR depressed AND [embase]/lim) OR ('depression'/exp AND [embase]/lim)) AND (('neoplasm'/exp AND [embase]/lim) OR ((tumor* OR tumour* OR cancer* OR carcinoma* OR malignan* OR neoplas*) AND [embase]/lim))<BR/>
<BR/>The above subject search was linked to the following Filter for EMBASE via EMBASE.com<BR/>((random*:ti,ab) OR (factorial*:ab,ti) OR (crossover*:ab,ti OR 'cross over':ab,ti OR 'cross over':ab,ti) OR (placebo*:ab,ti) OR ('double blind' OR 'double blind') OR ('single blind':ab,ti OR 'single blind':ab,ti) OR (assign*:ti,ab OR allocat*:ti,ab) OR (volunteer*:ab,ti) OR ('randomized controlled trial'/exp AND [embase]/lim) OR ('single blind procedure'/exp AND [embase]/lim) OR ('double blind procedure'/exp AND [embase]/lim) OR ('crossover procedure'/exp AND [embase]/lim)) NOT ((animal/ OR nonhuman/ OR 'animal'/de AND experiment/ AND [embase]/lim) NOT ((human/ AND [embase]/lim) AND (animal/ OR nonhuman/ OR 'animal'/de AND experiment/ AND [embase]/lim)) AND [embase]/lim) AND [embase]/lim<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>CINAHL via OVID</P>
</TD>
<TD>
<P>(Search Strategy as for MEDLINE but run with the following filter for Controlled Trials in CINAHL)<BR/>1. Random Assignment/<BR/>2. single-blind studies/<BR/>3. Double-Blind Studies/<BR/>4. Triple-Blind Studies/<BR/>5. Crossover Design/<BR/>6. Factorial Design/<BR/>7. (multicentre study or multicenter study or multi-centre study or multi-center study).mp. [mp=title, cinahl subject headings, abstract, instrumentation]<BR/>8. random$.ti,ab.<BR/>9. latin square.ti,ab.<BR/>10. cross-over.mp. or crossover.ti,ab. [mp=title, cinahl subject headings, abstract, instrumentation]<BR/>11. Placebos/<BR/>12. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab.<BR/>13. placebo$.mp. [mp=title, cinahl subject headings, abstract, instrumentation]<BR/>14. Clinical Trials/<BR/>15. (clin$ adj25 trial$).mp. [mp=title, cinahl subject headings, abstract, instrumentation]<BR/>16. or/1-15<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>PubMed Cancer Subset</P>
</TD>
<TD>
<P>#1 PSYCHOTHERAPY (MeSH)<BR/>#2 (psychotherap* or aromatherap* or (art AND therap*) or (autogenic AND training) or (behavior* AND therap*) or (behaviour* AND therap*) or (biofeedback and psycho*) or (cognitive AND therap*) or (desensiti* and psychol*) or (implosive AND therap*) or (relax* AND therap*) or (relax* AND techniq*) or (therap* AND touch*) or yoga)<BR/>#3 (bibliotherapy or (color* AND therap*) or (colour* AND therap*) or (music* AND therap*) or (hypno* AND therap*) or (imagery and psychotherap*) or counsel* or (group* AND therap*) or (socioenvironmental AND therap*) or (socio-environmental AND therap*) or (milieu AND therap*) or (therapeutic AND communit*) or (famil* AND therap*) or psychosoc* or psycholog* or (self AND help AND group*) or (support* AND group*) or (guide* AND image*)<BR/>#4 #1 OR #2 OR #3<BR/>#5 DEPRESSION (MeSH)<BR/>#6 depression or depressive* or depressed<BR/>#7 #5 OR #6<BR/>#8 NEOPLASMS (explode MeSH)<BR/>#9 tumor* or tumour* or cancer* or carcinoma* or malignan* or neoplas*<BR/>#10 #8 OR #9<BR/>#11 #4 AND #7 AND #10 All Fields, Limits: Cancer<BR/>
<BR/>The above search strategy was linked to the following Cochrane filter for PubMed:<BR/>(randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized controlled trials [mh] OR random allocation [mh] or double-blind method [mh] or single-blind method [mh] or clinical trial [pt] or clinical trials [mh] or ("clinical trial" [tw] or ((singl*) [tw] or doubl* [tw] or trebl* [tw] or tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR (placebos [mh] OR placebo* [tw] OR random* [tw] OR research design [mh:noexp]) NOT (animals [mh] NOT human [mh])<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>PsychINFO via OVID</P>
</TD>
<TD>
<P>1. exp PSYCHOTHERAPY/<BR/>2. (psychotherap$ or aromatherap$ or "art therap$" or "autogenic training" or "behavior$ therap$" or (behaviour$ adj6 therap$) or (biofeedback and psycho$) or (cognitive adj6 therap$) or (desensiti$ and psychol$) or "implosive therap$" or (relax$ adj6 therap$) or (relax$ adj6 techniq$) or (therap$ adj6 touch$) or yoga)<BR/>3. (bibliotherapy or (color$ adj6 therap$) or (colour$ adj6 therap$) or (music$ adj6 therap$) or (hypno$ adj6 therap$) or (imagery and psychotherap$) or counsel$ or (group$ adj6 therap$) or "socioenvironmental therap$" or "socio environmental therap$" or "milieu therap$" or "therapeutic communit$" or (famil$ adj6 therap$) or psychosoc$ or psycholog$ or "self help group$" or (support$ adj6 group$) or (guide$ adj6 image$))<BR/>4. or/1-3<BR/>5. exp RECURRENT DEPRESSION/ or exp REACTIVE DEPRESSION/ or exp TREATMENT RESISTANT DEPRESSION/ or exp "DEPRESSION (EMOTION)"/ or exp MAJOR DEPRESSION/<BR/>6. (depression or depressive$ or depressed)<BR/>7. or/5-6<BR/>8. exp NEOPLASMS/<BR/>9. (tumor$ or tumour$ or cancer$ or carcinoma$ or malignan$ or neoplas$)<BR/>10. or/8-9<BR/>11. 4 and 7 and 10<BR/>
<BR/>The above subject search strategy was run with the following filter:<BR/>CCT/RCT Filter for Embase (SRB revised)<BR/>1. (randomi$ or (control$ adj3 trial$)).mp. [mp=title, abstract, subject headings, table of contents, key concepts]<BR/>2. ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).mp. [mp=title, abstract, subject headings, table of contents, key concepts]<BR/>3. placebo$.mp. [mp=title, abstract, subject headings, table of contents, key concepts]<BR/>4. exp PLACEBO/<BR/>5. crossover.mp.<BR/>6. exp Treatment Effectiveness Evaluation/<BR/>7. or/1-6<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>LILACS via www.bireme.br</P>
</TD>
<TD>
<P>((psychotherapy OR psychotherap$ OR aromatherap$ OR (art AND therapy) OR (autogenic AND training) OR (behavior$ AND therapy) OR (behaviour$ AND therapy) OR (biofeedback AND psycho$) OR (cognitive AND therapy) OR (cognitive AND behavioural AND therapy) OR (cognitive AND behavioural AND therapies) OR (desensiti$ AND psychol$) OR (implosive AND therapy) OR (relaxation AND therapy) OR (relaxation AND therapies) OR (relaxation AND technique$) OR (theraputic AND touch) OR (touch AND therapy) OR (touch AND therapies) OR yoga OR bibliotherapy OR (color AND therapy) OR (colour AND therapy) OR (color AND therapies) OR (colour AND therapies) OR (music AND therapy) OR hypnotherapy OR (imagery AND psychotherap$) OR counsel$ OR (group AND therapy) OR (group AND therapies) OR (socioenvironmental AND therapy) OR (socio-environmental AND therapy) OR (milieu AND therapy) OR (therapeutic AND community) OR (family AND therapy) OR (family AND therapies) OR psychosoc$ OR psycholog$ OR (self AND help AND group) OR (self AND help AND groups) OR (support AND group) OR (support AND groups) OR (supportive AND group) OR (supportive AND groups) OR (guided AND imagery)) AND (depression OR depressive$ OR depressed OR depression) AND (neoplasms OR tumor$ OR tumour$ OR cancer$ OR carcinoma$ OR malignan$ OR neoplas$))<BR/>
</P>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>